Phytochemicals and bioactivities of cryptocarya nigra (lauraceae) / Ayu Afiqah Binti Nasrullah by Nasrullah, Ayu Afiqah
 PHYTOCHEMICALS AND BIOACTIVITIES OF 
CRYPTOCARYA NIGRA (LAURACEAE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AYU AFIQAH BINTI NASRULLAH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FACULTY OF SCIENCE 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
2014 
 
 PHYTOCHEMICALS AND BIOACTIVITIES OF 
CRYPTOCARYA NIGRA (LAURACEAE) 
 
 
 
 
 
 
 
 
AYU AFIQAH BINTI NASRULLAH 
 
 
 
 
 
 
A DISSERTATION SUBMITTED IN FULFILLMENT 
OF THE REQUIREMENTS FOR THE DEGREE OF 
MASTER OF SCIENCE 
 
 
 
 
 
 
 
 
 
DEPARTMENT OF CHEMISTRY 
FACULTY OF SCIENCE 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
2014
 
i 
 
ABSTRACT 
Phytochemical study and biological activity were conducted on Cryptocarya nigra 
(Lauraceae). C. nigra plant sample were collected from the Ulu Sat Reserved Forest, 
Machang, Kelantan.  Isolation of the secondary metabolites involved extraction, 
fractionation, and purification, using various chromatographic techniques. The structural 
elucidations were carried out via spectroscopic methods; notably 1D and 2D NMR (COSY, 
HMQC, HMBC, NOE-DIFF), MS, IR, UV and comparison with published data.  
In this study, a total of 8 known compounds were isolated from the samples of this 
plant species. Three phenanthrene alkaloids, namely atherosperminine 11, 2-
hydroxyatherosperminine 20, noratherosperminine 47, and a benzylisoquinoline alkaloid, 
(+)-N-methylisocolaurine 46 were isolated from the bark dichloromethane extract of C. 
nigra. The leaf alkaloid extract of C. nigra afforded two aporphines (isocorydine 48 and 
norisocorydine 49), a phenanthrene alkaloid, argentinine 50 and a non-alkaloidal 
compound, benzamide 51. This plant was being studied for the first time on their alkaloidal 
content.  
A dichloromethane extract of the stem bark of C. nigra showed moderate  
in vitro inhibition of Plasmodium falciparum growth, with an IC50 value of 2.82 μg/mL. (+)-N-
Methylisococlaurine 46, atherosperminine 11 and 2-hydroxy-atherosperminine 20 showed 
mild antiplasmodial activity (IC50: 5.40, 5.80 and 0.75 μM, respectively). In addition, 
compound 46 and 11 showed mild antioxidant activity in DPPH assay (IC50:  29.56 ug/mL 
and 54.53 ug/mL), FRAP assay (78.54 % and 70.66 %) and in the metal chelating assay (IC50: 
50.08 ug/mL and 42.87 ug/mL) respectively. No study has been reported on the antiplasmodial 
and antioxidant activities from Cryptocrya nigra. 
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ABSTRAK 
Kajian fitokimia dan aktiviti biologi telah dijalankan ke atas Cryptocarya nigra 
(Lauraceae). C. nigra telah diperolehi dari Hutan Simpanan Ulu Sat, Machang, Kelantan. 
Pengasingan metabolit sekunder melibatkan pengekstrakan, pengasingan, dan penulenan, 
melalui pelbagai kaedah kromatografi. Pengenalpastian struktur sebatian ditentukan 
melalui kaedah spektroskopi; iaitu 1D dan 2D NMR (COSY, HMQC, HMBC, NOE-
DIFF), MS, IR, UV dan melalui perbandingan data literatur. 
Dalam kajian ini, sebanyak 8 sebatian yang dikenali telah diasingkan daripada 
sampel ini spesies tumbuhan. Tiga alkaloid fenantrena, iaitu atherosperminina 11, 2-
hidroksiatherosperminina 20, noratherosperminina 47, dan benzilisokuinolina alkaloid, 
(+)-N-metilisokolaurina 46 telah diasingkan daripada ekstrak diklorometana batang C. 
nigra. Kajian ke atas ekstrak alkaloid daun C. nigra juga telah memberikan dua aporfina 
(isocoridina 48 dan norisocoridina 49), satu alkaloid fenantrena, argentinina 50 dan 
sebatian bukan alkaloid, benzamida 51. Pokok ini sedang dikaji untuk kali pertama bagi 
kandungan alkaloid mereka. 
Satu ekstrak diklorometana batang C. nigra menunjukkan sederhana dalam 
perencatan in vitro Plasmodium falciparum, dengan nilai IC50 2.82 μg/mL. (+)-N-
Methylisococlaurine 46, atherosperminine 11 dan 2-hydroxy-atherosperminine 20 
menunjukkan aktiviti antiplasmodial yang sederhana (IC50: 5.40, 5.80 dan 0.75 μM, 
masing-masing). Di samping itu, sebatian 46 dan 11 menunjukkan aktiviti antioksidan 
yang sederhana dalam DPPH assay (IC50: 29.56 g/mL dan 54.53 g/mL), FRAP assay 
(78,54% dan 70.66%) dan dalam kaedah chelating logam (IC50: 50.08 g/mL dan 42.87 
g/mL) masing-masing. Tiada kajian yang telah dilaporkan mengenai aktiviti 
antiplasmodial dan antioksidan daripada Cryptocrya nigra. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 General 
 
By definition, the word natural is an adjective referring to something that is 
present in or produced by nature and not artificial or man-made. When the word 
natural is used in verbiage or written, many times it is assumed that the definition is 
something good or pure. However, many effective poisons are natural products.
 [1]
 The 
term natural products today is quite commonly understood refering to herbs, herbal 
concoctions, dietary supplements, traditional Chinese medicine, or alternative 
medicine. 
[2]
  
 
Naturally occurring compounds may be divided into three broad categories. 
Firstly, there are those compounds which occur in all cells and play a central role in the 
metabolism and reproduction of those cells. These compounds include the nucleic acids 
and the common amino acids and sugars. They are known as primary metabolites. 
Secondly, there are high-molecular-weight polymeric materials such as cellulose, 
lignins, and proteins which form the cellular structures. Finally, there are those 
compounds that are characteristic of a limited range of species. These are secondary 
metabolites. The secondary metabolites from the plants include terpenoids and steroids, 
alkaloids, flavonoids, coumarins, antraquinones and tannins. 
[3]
 Natural products have 
been the source of most of the active ingredients of medicines. This is widely accepted 
to be true when applied to drug discovery in ‘olden times’ before the advent of high-
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throughput screening and the post-genomic era: more than 80% of drug substances 
were natural products or inspired by a natural compound. 
[4]
  
 
The development of high-throughput screenings, based on molecular targets, 
has led to a demand for the generation of large libraries of compounds. Malaysia, 
situated in the South East Asia, possesses one of the oldest and richest forests in the 
world.  It is reported that there are ~8000 angiosperms residing in this great forest. 
Thus the Malaysian flora is an excellent candidate to provide natural chemical 
substances. The Malaysian tropical rain forest comprises of more than 15,000 plant 
species and many of them have been claimed to possess medicinal properties. 
[5]
 In 
recent years a rich harvest of novel natural products had been made, some of which 
possess cytotoxic or insecticidal activities. Some of the diverse classes of natural 
products, e.g. acetogenins, alkaloids, biflavonoids, coumarins, terpenoids and 
xanthonoids, are isolated from Malaysian plant families. 
[6]
 The variability of species 
that are commonly used as traditional medicines belongs to the families of 
Leguminocae, Rubiaceae, Lauraceae, Apocynaceae, Rutaceae, Moraceae, Meliaceae 
and Anonaceae. For examples, Phyllanthus niruri (dukung anak), Andrographis 
paniculata (hempudu bumi), Eurycoma longifolia (tongkat ali), Labisia pumila (kacip 
fatimah), Pipper bettle (sirih), Centella asiatica (pegaga), Hibiscus rosasinensis (bunga 
raya) and Strobilanthes cripspa (serus). 
[7-8]
 
 
In short, this thesis reports on the phytochemistry and bioactivity of 
Cryptocarya nigra from the family Lauraceae. This study mainly deals with isolation, 
structure elucidation of natural products, and their bioactivities. No study has been 
reported on the alkaloids, antiplasmodial and antioxidant activities from Cryptocarya 
nigra. 
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1.2 Objectives of Study 
The objectives of this study are:  
(1) To extract the crude alkaloids from the barks and leaves of 
Cryptocarya nigra (this is the first report on the alkaloids of 
Cryptocarya nigra) by using dicholoromethane (CH2Cl2) as a solvent 
and to purify the known and new alkaloids by using chromatographic 
techniques such as column chromatography (CC) and preparative thin 
layer chromatography (PTLC). 
(2) To elucidate the structure of both novel and known compounds 
isolated from Cryptocarya nigra by using spectroscopic methods 
mainly 1D-NMR (
1
H, 
13
C and DEPT-135), 2D-NMR (COSY, HMBC, 
HMQC and NOESY), Ultraviolet (UV), Infrared (IR) and LCMS-IT-
TOF.  
(3) To evaluate the antiplasmodial and antioxidant activities of the 
isolated alkaloids and extracts of Cryptocarya nigra. 
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1.3 Lauraceae Family: General Appearance and Morphology 
 
The family Lauraceae belongs to the Order Laurales that is classified in the 
Subclass Magnoliidae. 
[9-10]
 The family is pantropical, including about 50 genera with a 
probable number of 2500 to 3500 species world-wide, mostly from warm to tropical 
region, especially Southeast Asia and Brazil. 
[11-12]
  
 
Trees of the Laurel family predominate in the world's Laurel forests, which 
occur in a few humid subtropical and mild temperate regions of the northern and 
southern hemispheres, including the Macaronesian islands, southern Japan, 
Madagascar, and central Chile. 
 
In Malaysia, there are 213 species of Lauraceae. In the lowland of Malaysia 
members of Lauraceae are typically small trees of the canopy except for a few species 
which may reach 30m tall. In the highland, the Lauraceae becoming more abundant 
reaching the top layer of the forest canopy and thus the term “oak laurel forest” is given 
to this vegetation which lies at altitude 1200-1600m. 
[13]
 
 
The timber of Lauraceae is light hardwood with trademark name Medang or 
Tejur. The timber is of no great commercial importance although trees of commercial 
size are felled. They are suitable for decorative work such as interior finishing, 
panelling, furniture and cabinetmaking. The timber is also suitable for plywood 
manufacture and the heavier species could be utilized for medium construction under 
cover 
[14]
. The family of Lauraceae provided many useful economic products. Most of 
the economically important species other than sources of excellent wood are spices or 
flavoring agent. For example avocado (Persea) is one of important tropical fruit. 
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1.4 Classification of Tribe 
 
There are many primitive and archaic features, which characterize the 
Lauraceae family. The determination is dependent on a combination of characters. List 
below illustrates the classification proposed by Hsuen Keng. There are over 30 genera, 
mainly tropical and sub-tropical Asia and America, about 16 are found in Malaysia. 
This classification is according to Malayan seed plants. 
[7]
 However, according to Judd 
et al. (2007), the classification proposed by Van Der Werff and Richter (1996) is 
presently used. They were classified based on both inflorescences structure and wood 
anatomy which divides the Lauraceae family into two sub-families; Lauroideae and 
Cassythoideae as shown in Scheme 1.1. 
 
Kingdom  : Plantae 
Divison     : Magnoliophyta 
Class         : Magnoliopsida 
Order        : Laurales 
Family       : Lauraceae 
Genera : 
Actinodaphne Adenodaphne Aiouea 
Alseodaphne Anaueria Aniba 
Apollonias Aspidostemon Beilschmiedia 
Brassiodendhron Caryodaphnopsis Cassytha 
Chlorocardium Cinnadenia Cinnamomum 
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Clinostemon  Cryptocarya Dahlgrenodendrone 
Dehaasia Dicypellium Dodecadenia 
Endiandra Endlicheria Eusideroxylon 
Gamanthera Hexapora Hypodaphnis 
Iteadaphne Kubitzkia Laurus 
Licaria Lindera Litsea 
Machilus Mezilaurus Mochinnodaphne 
Mutisiopersea Nectandra Neocinnamomum 
Neolitsea Notaphoebe Ocotea 
Paraia Parasassafras Persea 
Phoebe Phyllostemonodaphne Pleurothyrium 
Potameia Potoxylon Povedadaphne 
Ravensara Rhodostemonodaphne Sassafras 
Sextonia Sinosassafras Syndiclis 
Triadodaphne Umbellularia Urbanodendron 
Williamodendron Yushunia  
 7 
 
  
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.1: Classification of Family Lauraceae 
Order: Laurales 
 Family:  Lauraceae 
Sub-family: 
Lauroideae 
Cinchonoideae 
Sub-family: 
Cassythoideae 
Tribe: 
Perseeae 
Cinnamomone 
Corytocaryeae 
Lauraceae 
 
Tribe: 
Cassytha 
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1.5 The Genus Cryptocarya 
 
The genus Cryptocarya belongs to the family Lauraceae, comprises more than 
350 species
 [15]
 and 19 species are found in Malaysia. 
[16]
 This genus is distributed 
through the Neotropic, Afrotropic, Indomalaya and Australasia ecozones and also 
found in Southern Brazil. In Malaysia, they are called medang by local trade name 
while in Philpines, they were known as dugkatan and manayau. 
[17]
 
 
The species of the genus Cryptocarya  found in Malaysia are C. bracteolata, C. 
caesia, C. costata, C. crassinervia, C. densiflora, C. enervis, C. ferrea, C. griffithiana, 
C. impressa, C. infectoria, C. kurzii, C. laevigata, C. nigra, C. nitens, C. rugulosa, C. 
scortehinii, C. teysmanniana, C. tomantosa, C. wrayi and C. zollingeriana. 
 
Cryptocarya can be distinguished from other laurel genera by its bisexual and 
trimerous flowers, which are very typical in shape (usually slender, urceolate, apically 
narrowed tube and immersed ovary, six equal to subequal tepals, nine fertile stamens 
with disporangiate anthers, staminal glands only in the third androecial whorl), and by 
the characteristic fruit that is enclosed by the accrescent flower tube. 
[18]
 The leaves are 
alternate, pinnatinerved, rarely trinerved. Inflorescenses in axillary or sub terminal 
panicles. The flowers are bisexual (perianth tube turbinate or ovoid), lobes 6, stamens 
usually 9. The fruits entirely included in the enlarge perianth tube leaving only a minute 
opening at apex. 
[16]
 It is found in low elevation evergreen forests and littoral rainforest, 
usually on all type of soils. The seeds are readily dispersed by fruit-eating birds, and 
seedlings and saplings have been recorded from other habitats where they are unlikely 
to develop to maturity. 
[15]
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Several species from this genus have been used widely in traditional 
medication, essential oil and also used as sources of timber for house construction and 
furniture due to the characteristic of the wood which are finely grained, more or less 
heavy and durable 
[19]
. Many reported phytochemical and pharmacological studies on 
this genus shown the chemical constituents to consist typically pyrones and 
styrylpyrones which exhibit anticancer activities. Examples are Cryptocarya 
massoia which is used commercially to produce essential oil and Cryptocarya 
alba produces a very hard wood which is highly valued. Cryptocarya woodii leaves 
have been found in prehistoric settlements in Africa and are believed to have been used 
for insect control.
 [15]
 
 
1.6 Cryptocarya nigra 
 
Cryptocarya nigra is a medium sized tree up to 10 m tall with about 15 cm 
diameters. The bark is white-grey brown and smooth. The inner bark is pinkish red and 
mottled white while the young twigs of this species are velvety hairy. Cryptocarya 
nigra leaves are spirally simple, thickly coriaceous from elliptic to elliptic lanceolate or 
elliptic ovate.  They are apex shortly pointed, asymmetric, base obtuse with 8.0-14.5 
cm x 5.0-6.5 cm. The upper surface is bright green with glaucous color below it. The 
young leaves secondary nerves 7-11 pairs which are raised below and faint above it. 
The tertiary nerves are in scalari form. The petioles are up to 1.5 cm long. Cryptocarya 
nigra flowers are yellow with inflorescence in axillaries and terminal panicles. 
The species can be found in undisturbed mixed dipterocarp forests up to 300 m 
altitude in Sumatra, Borneo (Sarawak, Sabah, and East-Kalimantan), and usually on 
hillsides with sandy soils. In secondary forests this species usually present as a pre-
disturbance remnant tree. 
[20]
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Figure 1.1: Leaves of Cryptocarya nigra Kosterm 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Bark of Cryptocarya nigra Kosterm 
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1.7 Medicinal Value 
 
Sustainable management of traditional medicinal plant resources is important, 
not only because of their value as a potential source of new drugs, but due to reliance 
on traditional medicinal plants for health. 
[25]
 The World Health Organization (WHO) 
estimates that approximately 80 percent of the world’s population relies primarily on 
traditional medicines as sources for their primary health care. 
[26]
 Natural products have 
been the single most productive source of leads for the development of drugs. Natural 
products have been the source of most of the active ingredients of medicines. 
 
Plants have always been the single most productive source of lead compounds 
(e.g. morphine, cocaine, digitalis, quinine, tubocurarine, nicotine, and muscarine). 
Many of these lead compounds are useful drugs in themselves (e.g. morphine and 
quinine), and others have been the basis for synthetic drugs (e.g. local anaesthetics 
developed from cocaine). Clinically useful drugs which have been isolated from plants 
include the anticancer agent paclitaxel from the yew tree, and the antimalarial agent 
artemisinin from Artemisia annua. Plants provide a large bank of rich, complex and 
highly varied structures which are unlikely to be synthesized in laboratories. 
Furthermore, evolution has already carried out a screening process itself whereby plants 
are more likely to survive if they contain potent compounds which deter animals or 
insects from eating them. Even today, the number of plants that have been extensively 
studied is relatively very few and the vast majorities have not been studied at all. 
[27]
 
During the 19
th
 century, organic chemists took up the study of many plant 
principles, the physiological effect of which had been recognized. A new impetus was 
given to the search for medicinal plant principles by the discovery of the clinical 
usefulness of alkaloids of Rauwolfia species and during the past dozen years this has 
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provided fresh stimulus for an enlarged and concentrated attack upon the still 
unexplored botanical resources of the world. 
[28]
 
 
Cryptocarya massoy is a native of New Guinea. In Peninsular Malaysia, the 
bark of this species is used by the women after childbirth, and also is added to tonics 
and cigarettes. In Indonesia, it is used against diarrhea and spasmodic bowel trouble, 
usually in combination with a Cinnamon. Furthermore, it is an ingredient of various 
native medicines and has a characteristic odor. In New Guinea, the aromatic bark of 
Cryptocarya massoy is employed to treat fever, and often it is used by the natives to 
treat bad cases of tuberculosis of the lungs. A small portion of the bark is placed so as 
to close a fresh wound. It is also chewed and the saliva rubbed over the limbs to ease 
muscular pains. In small quantities, mostly in combination with other vegetable drugs, 
it is ingested for violent headache, pain in the joints, puerperal infection, distention of 
the stomach, vomiting and chronic constipation; it is also mixed with cloves and 
sandalwood and used by the natives as rubefacient. The volatile oil of the bark contains 
pinene, limonene, dipentene, eugenol and safrol. 
[29]
 
 
Past studies of the species of Cryptocarya chinensis have found that it contains 
many pavine and proaphorpine alkaloids.
 [30-34]
 The pavine alkaloids have been noted to 
possess antiviral and immunological activity
 [35]
, behavioral and electrophysiological 
effects, and antiarrhythmic potential.
 [32]
 Several other compounds were isolated by 
Horn et al. from the leaves and bark of the South African plant. Cryptocarya latifolia, 
which has long been noted for its medicinal properties.
 [36]
 These range from the 
treatment of headaches and morning sickness to that of cancer, pulmonary diseases and 
various bacterial and fungal infections. 
[37]
 Phytochemical studies on stem bark and 
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leave of Cryptocarya moschata from Atlantic Rain Forest show the occurrence of 
styrylpyrones and flavonoid glycosides on this species. Some of the pyrones and 
styrylpyrones isolated from this genus have shown larvicidal and antifertility activities, 
as well as inhibition of breast cancer cell lines.
 [38]
 
 
 In Brazilian Atlantic rain forest, the fruits of the species Cryptocarya 
mandioccana Meisner are distinct by their aroma and pungent flavor, being carminative 
and with stomachic properties. Its bark, bitter and scented is also considered to be 
stomachic and helpful in fighting colic and diarrhea. The tea from its seeds is used 
against stomachache, and it’s crushed leaves against aches and colic. [39] 
  
 
 
 
 
CHAPTER 2 
 
 
GENERAL CHEMICAL 
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CHAPTER 2 
GENERAL CHEMICAL ASPECTS 
 
2.1 Introduction 
 
Natural products chemistry can be thought of as originating from mankind’s 
curiosity about odor, taste, color, and cures for diseases. Folk interest in treatments for 
pain, for food-poisoning and other maladies, and in hallucinogens appears to go back to 
the dawn of humanity. For centuries China has led the world in the use of natural 
products for healing. Nowadays, due to the rising of interest concerning on research in 
the scope of medicinal importance, organic chemist had begun the investigation on 
alkaloids containing and its usage in either traditional or modern medicine.  
 
The explorations of the Lauraceous plants have been intensified since many 
decades ago for alkaloids due to its medicinal value. The medicinal value of this plant 
is inestimable. For examples, herbalism and folk medicine, ancient and modern, have 
been the source of much useful therapy, pharmacology and taxonomy. These chemical 
compounds also important to economic and nutrition field. Besides alkaloids, they 
produced a wide range of non-alkaloidal compounds including carbohydrate, proteins, 
lipid, amino acids, terpenes, essential oils, acetogenins, polyphenols and aromatic 
compounds. 
[40]
 
 
The major source of alkaloids is the angiosperms, but alkaloids are also found 
in animals, insects, microorganisms, and lower plants. Human have utilized alkaloids as 
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medicines, poisons, and magical potions. The alkaloids are one of the most diverts 
groups of secondary metabolites found in living organisms and have an array of 
structure types, biosynthetic pathways, and pharmacological activities and are of 
limited distribution in the plant kingdom. It contains secondary, tertiary, or quaternary 
nitrogen atoms in their structures. Their amine character produce an alkaline solution in 
water and hence the origin of their name-alkaloid. 
 
2.2 Alkaloid: Definitions 
  
Human recognition of alkaloids is as old as civilization, since these substances 
have been used as drugs, in potions, medicines, teas, and poisons for 4000 years. The 
research on alkaloids is growing rapidly. Researchers are determined in attempting to 
decode the many secrets surrounding alkaloids. Thus, the level of scientific research 
activity in connection to alkaloids is high internationally. 
 
The term alkaloid coined in 1819 by the pharmacist W. Meissner and meant 
simply, “alkali-like”. [41] This term is applied to nitrogen containing molecules 
belonging to one of the largest and most diverse families of naturally occurring 
compounds which usually contain nitrogen as part of heterocyclic system. These 
compounds are grouped together by the presence of nitrogen atom in their structure. 
[42]
 
 
An “alkaloid” is a substance with nitrogen in the molecule, connected to at least 
two carbon atoms and must have at least one ring, but not necessarily heterocyclic was 
proposed by Nowacki and Nowacka (1965). Alkaloids are grouped in three main 
categories based on knowledge and speculation about their biogenesis. 
[16]
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Alkaloids are a group of molecule with relatively large occurrence in nature 
around the Globe. They are very diverse chemicals and biomolecules, but they are all 
secondary compounds and derived from amino acids or from the transamination 
process. Similar alkaloids can have quite different biosynthetic pathways and different 
bioimpacts. Alkaloids are derived from l-lysine, l-ornithine, l-tyrosine, l-tryptophan, l-
histidine, l-phenylalanine, nicotinic acid, anthranilic acid or acetate. The terpenoid, 
steroid and purine alkaloids are also important. Millions of people around the Globe 
use purine alkaloids every day whether starting the day with a cup of coffee or drinking 
a cup of tea in the afternoon. 
[43]
 
 
Alkaloid chemistry underlies the significance of the blocks, pathways and 
transamination reactions. The main criteria for alkaloid precursor determination are the 
skeleton nucleus of the alkaloid. The following is most important alkaloid nuclei exists; 
piperidine, indolizidine, quinolizidine, pyridon, pyrrolidine, imidazole, quinazoline, 
quinoline, pyridine, sesquiterpene, indole, and purine. Several examples of common 
alkaloid ring skeletons are illustrated in Scheme 2.1. They can be isolated, detected and 
modified. Modification of alkaloids by chemical and biological processes and 
bioengineering can produce new applications. Chemistry are not only investigates 
alkaloids, their structures and activities, but also develops method for their structural 
manipulation. 
[43]
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           Pyrolidine                                     piperidine                                   pyridine 
 
 
 
 
indolizidine                                     quinolizidine                          pyrrolizidine 
 
 
 
 
          Indole                                 quinoline                               isoquinoline 
 
 
 
 
 
        Purine                                        quinazoline                                 tropane 
 
 
Scheme 2.1: Examples of Alkaloid Ring Skeletons. 
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2.3 Alkaloids: Occurrence and Distribution [41,44] 
 
The major source of alkaloids in the past has been the flowering plants, the 
Angiospermae, where about 20% contain this constituent, and it is estimated that they 
are present in only 10-15% of all vascular plants. The production of alkaloid has been 
found to be associated with living rather than dead cell tissue, and in some cases the 
amount of alkaloids present seems to vary with time and with degree of maturation of 
the plant. They are rarely found in cryptogamia (exception – ergot alkaloids), 
gymnosperms, or monocotyledons.  
 
They occur abundantly in certain dicotyledons and particularly in the families of  
Apocynaceae (dogbane, quebracho, pereiro bark), Papaveraceae (poppies, 
chelidonium), Papilionaceae (lupins, butterfly-shaped flowers), Ranunculaceae 
(aconitum, delphinium), Rubiaceae (cinchona bark, ipecacuanha), Rutaceae (citrus, 
fagara) and Solanaceae (tobacco, deadly nightshade, tomato, potato, thorn apple). Well 
characterized alkaloids have been isolated from the roots, seeds, leaves or bark of some 
forty plant families and it is probable that the remaining families will provide only an 
occasional alkaloid-bearing plant.  
 
It is generally true that a given genus or related genera yield the same or 
structurally related alkaloids; for example, seven different genera of Solanaceae contain 
hyoscyamine. In recent year an increasing numbers of examples of alkaloids have come 
from animals, insects, marine organisms, microorganisms, and lower plants. 
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2.4 Function of Alkaloids [45] 
 
The reasons why plants produce alkaloids is mostly unknown. Although various 
theories have been proposed to explain their existence, but the function of alkaloids is 
still vague and not really understood by the chemist. Some of the suggested functions 
are listed as the following: 
 
 
 As by-products of normal plant metabolism or waste products 
 As storage reservoir of nitrogen for protein synthesis 
 As protections against damage by ultraviolet light. 
 As defense chemicals (agent as a toxic) for the plants against attack by 
predators (insects or herbivores). For this function, alkaloids must closely 
interact with specific targets in herbivores. 
 As plants stimulants and regulators in such activities as growth, metabolism and 
reproduction. 
 As substitutes of mineral in the plants such as potassium and calcium 
 As a detoxification agent, which render harmless, by processes such as 
methylation, condensation, and ring closure, substances whose accumulation of 
which might otherwise cause damage to the plant. 
  
In conclusion, one might say that while much has been learned about the 
biogenesis and metabolism of alkaloids, their functions in the plants, if any, are still 
largely unknown. 
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2.5 Classification of Alkaloids [46] 
 
Chemical, pharmacological, botanical properties must all be considered in 
classifying a compound as an alkaloid. Alkaloids are grouped in three main categories 
(Scheme 2.2) based on both of knowledge and speculation about their biogenesis 
(Scheme 2.3). 
 
 True Alkaloid 
The true alkaloids are compounds in which the nitrogen-containing 
heterocyclic system is derived from a biogenetic amine, formed by 
decarboxylation from an amino acid. They are usually found as salts in 
plant such as liriodenine 1 and morphine 2. 
 
 
 Pseudo Alkaloid 
Pseudo alkaloids are apparently unrelated to acid amino. They are 
nitrogen containing molecules but they have carbon skeletons derived 
from monoterpenes and other acetate derivatives and aliphatic 
polyketoacids such as coniine 3 and β-skytanthine 4. 
 
 Proto Alkaloid 
These compounds like true alkaloids, derived from an amino acid or 
biogenetic amine but they do not contain any heterocyclic system and 
represented in nature by biogenetic amine themselves and their 
methylated derivatives such as serotonins 5 and mescaline 6. 
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Scheme 2.2: Examples of Alkaloids Based on Three Main Categories 
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Scheme 2.3: Classification of Alkaloids with the Biogenesis Concept 
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Classification of alkaloids can also be done based on their biogenesis criteria. 
Examples for biogenesis classification are aporphine and benzylisoquinolines (Scheme 
2.4) and phenanthrene (Scheme 2.5) type of alkaloids. Biosynthesis is the experimental 
study of the formation of secondary metabolites. Thus, biogenesis is the hypothetical 
speculation on the precursor – product relationship in a biosynthetic pathway. Most of 
alkaloids of Lauraceae, are isoquinoline type derived from 
tetrahydrobenzylisoquinoline which was originated from tyrosine. 
 
Experiment with labeled precursor and cell cultures showed that condensation 
between 4-hydrophenylacetaaldehyde 7 from amino acid tyrosine 8 and dopamine 9 
yielded the first alkaloid intermediate (S)-norcoclaurine 10, which mark the first and 
central intermediate of isoquinoline alkaloids. Intramolecular oxidative reaction from 
the benzylisoquinolines, (S)-norcoclaurine 10 gives aporphine structure 
[47-48]
 (Scheme 
2.4). 
 
Although no labeling experiments have yet done, there is complete agreement 
concerning the origin of phenanthrene alkaloids from aporphines. In fact, we may 
safely assume that phenanthrene alkaloids with a 2-dimethylamino side chain derive 
from quaternary aporphinium salts by in vivo Hoffmann elimination. Example, 
according to Batthacharya et al. mentioned that the phenanthrene alkaloid, 
atherosperminine 11 is formed from the Hoffman elimination product of aporphine 
alkaloid, (-) – Nuciferine 12 (Scheme 2.5) [49]. 
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Scheme 2.4: Biosynthesis of Benzylisoquinoline and Aporphine Alkaloids from  
Tyrosine 8 
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Scheme 2.5: Biosynthesis of Phenanthrene Alkaloid 11 from Nuciferine 12 
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2.6 Interest in Alkaloids 
 
For many years, the nature of alkaloid in plant metabolism was a mystery. 
There are many explanations why plants, micro-organisms and animals produce 
alkaloids. Despite years of advanced research in the field, a final comprehensive 
biological explanation of the nature of alkaloid is still on the way. Furthermore, the 
discoveries of structure of alkaloids are unexpected and the biological activity is 
surprising. Based on the theoretical hypotheses on the nature of alkaloid compiled 
during the last 200 years, alkaloids are hypothesized as plant wastes and end products 
of metabolism. 
[50]
 
 
Almost all alkaloids have been found to possess some kinds of pharmacological 
activity, ranging from extreme toxicity to their use as valuable pharmaceuticals. 
Despite the increasing interest of public in phytomedicine, very few drugs from higher 
plants have attained any prominence in conventional medicinal practice in the last 
couple of decades. The most notable example is Taxal, a diterpenoid originally 
obtained from the bark of the Pacific yew tree (Taxus brevifolia Nutt.). Instead, major 
progress in the last decade has been in the field of phytomedicine, also referred to as 
botanicals or herbal medicine. In Germany and many European countries, these 
products are classified as drugs; and in USA they are sold as dietary supplements. 
[51]
 
 
Alkaloids applications can be found in different areas. Some alkaloids are still 
used in modern medicine today as natural or modified compounds. Their use is 
connected to the regulation of Na
+
 ions and channels, mescaric, cholinergic receptor, 
acetylcholine-esterase, opiod and opiate receptors, glycine and other receptors, as well 
as the regulation of micro-tubules of the spindle apparatus. Moreover, alkaloids are 
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used in the regulation of microbial and schizonticide activity and as pharmaceuticals. 
Some alkaloids are used in food receptors as additional components or are consumed as 
part of the final product (caffeine, theophylline, piperine, and capsaicin). The use of 
alkaloids as a supplement in some products on the market is presently a matter of 
discussion, as they are considered a health risk (the case of ephedrine). Alkaloids can 
also be used as biological fertilizers and as control agents in plant protection. 
[52]
  
 
In summary, the main interests in the alkaloids at the present time are (a) the 
nature of, and the reason for their pharmacological effects in human; (b) the chemical 
and physical-chemistry properties associated with them, and (c) how and why they are 
synthesized in the plant (their biosynthesis). 
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2.7  Alkaloids Isolated from Cryptocarya species    
Phytochemical studies on several species of Cryptocarya have been reported 
before as shown in Table 2.1. Several types of alkaloids were isolated and reported 
including some new compounds.  
 
Table 2.1: Alkaloids Isolated from the Genus of Cryptocarya 
Plant Alkaloids Isolated 
Cryptocarya chinensis
21
 
 
(+)-eschscholtzidine-N-oxide 13 
(-)-12-hydroxycrychine 14 
(-)-12-hydroxy-O-methylcaryachine 15 
(-)-N-demethylcrychine 16 
isocryprochine 17 
isoamuronine 18 
(+)-8,9-dihydrostepharine 19 
Crptocarya crassinervia
22
 2-hydroxyatherosperminine 20 
N-demethyl-2-methoxyatherosperminine 21 
2-methoxyatherosperminine 22 
2-methoxyatherosperminine N-oxide 23 
Cryptocarya oubatchensis
 23
 oubatchensine 24 
Cryptocarya konishii
24
 oblongine 25 
methyloblongine 26 
Cryptocarya rugulosa
53
 
 
dicentrinone 27 
atheroline 28 
 
Cryptocarya phyllostemon
54
 (-)-antotine 29 
(-)-phyllostemine 30 
(-)-phyllosteminine 31 
(+)-phyllocryptonine 32 
(+)-phyllocryptine 33 
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Figure 2.1: Structures of Alkaloids from the Cryptocarya 
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Figure 2.1: continued 
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Figure 2.1: continued 
 32 
 
 
 
 
 
 
                                                                       
                                                                      33 
Figure 2.1: continued 
 
2.8 Isoquinoline Type of Alkaloids 
 
Isoquinoline is chemically known as benzo [c] pyridine or 2-benzanine. The 
alkaloids that possess isoquinoline skeletons are known as isoquinoline alkaloids. 
Various types of isoquinoline alkaloids may be found in Lauraceae with aporphine 
being the major group of this type. 
[55]
 
 
The isoquinoline backbone is biosynthesized from the aromatic amino acid 
tyrosine 8 (Scheme 2.4). Isoquinoline is a colourless hygroscopic liquid at room 
temperature and known as a weak base with pKa of 8.6 and has unpleasant odor. It is 
slightly soluble in water but well soluble in common organic solvents. Isoquinoline can 
be categorized into several classes based on the skeleton of the structure (Table 2.2). 
The benzylisoquinoline, aporphine and phenanthrene alkaloid will be discussed briefly 
in the next section since the author has isolated this type of alkaloids from the plant 
species studied. 
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Table 2.2: Categories of Isoquinoline Alkaloids 
[56]
 
Simple isoquinoline Dibenzazonines 
Benzylisoquinoline Protoberberines and retroprotoberberines 
Isoquinolones Secoberberines 
Pavines and isopavines Benzophenantridhines 
Bisbenzylisoquinolines Arylisoquinolines 
Baluchistanamines Protopines 
Cularines Phthlideisoquinolines 
Dibenzopyrrocolines Rhoeadines 
Proaporphines Emetines 
Aporphines Phenethylisoquinolines 
Proaporphine-benzylisoquinoline Homoaporphines and homoproaporphines 
Dimmers 1-Phenylisoquinolines 
Aporphine-pavine dimmers N-Benzyltetrahydroisoquinolines 
Oxoaporphines 4-Arylisoquinolines 
Aristolochic acid and aristolactams Azafluoranthenes and tropolosoquinolines 
Phenanthrene 1, 6-Diazafluoanthenes 
 
The isoquinoline alkaloids are a large class of medicinally active alkaloids with 
a wide variety of properties. Their properties include being antispasmodic, 
antimicrobial, antitumour, antifungal, anti-inflammatory, cholagogue, hepatoprotective, 
antiviral, amoebicidal, anti-oxidant and can act as enzyme inhibitors.  
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2.8.1 Benzylisoquinolines 
 
 
 
The benzylisoquinoline types of alkaloids are derived from phenylalanine or 
tyrosine and are the parent skeleton of a wide variety of alkaloids possessing numerous 
different ring systems. There are two types of benzylisoquinoline, i.e. 1, 2, 3, 4-
tetrahydro isoquinoline such as orientaline 34 and a fully aromatic type such as 
papaverine 35. 
 
 
 
 
 
 
 
 
 
Benzylisoquinoline alkaloids are widely distributed in the family Anonaceae 
[57-
59]
, Lauraceae 
[60-63]
, Menispermaceae 
[64-65]
, Papaveraceae 
[66-67]
, Fumariaceae 
[68-69]
, 
Ranuculaceae 
[70-71]  
and Berberidaceae 
[72-73]
. 
34 35 
 35 
 
1
H NMR 
 
The 
1
H NMR data of benzylisoquinoline (Table 2.3) shows a number of 
interesting features due to the one asymmetric center at C-1. The H-1 showed a triplet 
or doublet-doublet (J1 = 8-9, J2 = 1.5-3 Hz) with chemical shift (in CDCl3) between δ 
3.6-3.7 while the aliphatic proton signals for H-3, H-4 and H-α, normally appeared as 
multiplet at δ 2.5-3.5. 
 
The methylenedioxy protons resonate at δ 5.6-6.0. Base on the study of 
benzylisoquinoline compounds, this group can be attached to C-6,7 and C-3’,4’. 
Methylenedioxy protons attached to C-6 and C-7, the signal showed as a doublet or 
singlet in the proton NMR spectrum. The methoxyl groups of the benzylisoquinoline 
generally resonate at δ 3.50-4.00. Normally, N-methyl groups resonated in the region of 
δ 2.4-2.6. Table 2.3 shows examples of chemical shift of 1H NMR for some 
benzylisoquinoline alkaloids, i.e. hydrocotarnine 36, laudanosine 37, and laudanine 38. 
 
 
 
 
 
                         
                     36                                     37  R1 = CH3, R2 = CH3 
                                                                  38   R1 = CH3, R2 = H            
                                                                   
 
 
 36 
 
Table 2.3: 
1
H NMR (in CDCl3, ppm) for hydrocotarnine 36, laudanosine 37, 
and laudanine 38. 
Position of H 36 37 38 
H-1 3.44 3.64 3.64 
H-3 2.60 2.73 and 3.12 2.74 and 3.09 
H-4 2.80 2.55 and 2.78 2.57 and 2.74 
H-5 6.31 6.50 6.45 
H-6 - - - 
H-7 - - - 
H-8 - 6.02 5.81 
H-α - 2.17 and 3.10 2.54 and 3.03 
H-2’ - 6.55 6.58 
H-3’ - - - 
H-4’ - - - 
H-5’ - 6.71 6.60 
H-6’ - 6.58 6.36 
6-OCH3 - 3.77 3.68 
7-OCH3 - 3.53 3.37 
8-OCH3 3.98 - - 
4’-OCH3 - 3.78 3.68 
5’-OCH3 
N-CH3 
- 
2.45 
3.73 
2.49 
- 
2.40 
OCH2O 5.85 - - 
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13
C NMR 
 
In the 
13
C NMR spectra, C-1 normally resonates at δ 52-58, but it resonates at 
higher field i.e. δ 60-67 in the presence of N-methyl group. Substituted carbons N-
methyl, methoxyl and methylenedioxy appears at δ 40-45, δ 54-63 and δ 100-103, 
respectively. The quaternary carbon at the position 4a, 8a and 1’ resonates at δ 115-132. 
The quaternary carbons with methoxyl and hydroxyl groups appear at δ 140-152. 
Unsubstituted sp
2
 carbons usually appear at δ 100-130 and the sp3 carbons at the 
position C-α and C-3 resonate at δ 38-40 and δ 45-46, respectively. The chemical shift 
of C-4 with N-methyl group in the structure appears at δ 23-24, but it will appear at δ 
28-29 in the absence of the N-methyl group. 
 
Mass Spectrometry 
 
In the mass spectra of benzylisoquinoline, the main cleavage occurs between C-
1 and C-α to form an imine ion. The fragment ion corresponding to m/z 192 appears as 
a base peak indicating that C-6 and C-7 are substituted with methoxyl and hydroxyl 
groups respectively, and the structure bears a N-methyl group. If both C-6 and C-7 are 
substituted by methoxyl groups, the peak at m/z 206 corresponds to the base peak. The 
appearance of a base peak at m/z 176 indicates that C-6 and C-7 are attached to a 
methylenedioxy moiety without N-methyl in the structure. 
 
Compounds having a methoxyl and hydroxyl groups in ring C displayed a peak 
at m/z 137. Two methoxyl groups attached to C-3’ and C-4’ showed the fragmentation 
peak at m/z 151 and a hydroxyl group in the ring C showed peak at m/z 107. 
[74]
 An 
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illustration of the mass fragmentation pattern of benzylisoquinoline is shown in Scheme 
2.6. 
  
 
 
  
 
              m/z = 192       R1 = OCH3, R2 = OH, R5 = CH3   ;    m/z = 107      R3 = H, R4 = OH 
                             m/z = 176      R1 = R2 = OCH2O, R5 = H           ;  m/z = 121      R3 = OCH3, R4 = H 
                             m/z = 206      R1 = R2 = OCH3, R5 = CH3               ;   m/z =137       R3 = O3 H, R4 = OCH3 
 
Scheme 2.6: Illustration of the Mass Fragmentation Pattern of Benzylisoquinoline. 
 
Ultraviolet Spectrocopy 
 
The ultraviolet spectra of benzylisoquinoline show a maxima between 280 and 
296 nm which has little effect by addition of aromatic substitution. Fully aromatic 
compounds having a methylenedioxy show more intensity absorption maximum. 
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2.8.2 Aporphines 
 
 
 
 
 
 
 
Aporphinoid alkaloids are known to possess medicinal properties. More than 
600 aporphinoid alkaloids have been isolated from 19 plant families and many of those 
plants are used as folk medicines in different parts of the world for the treatment of 
several kinds of diseases. The family Lauraceae, Berberidacaeae, Magnoliaceae, 
Menispermaceae, Ranuculaceae, Monimiaceae, Pavaperaceae, and Annonaceae. 
[75-76]
 
 
Aporphine alkaloids are the largest group within the isoquinoline alkaloids. It 
contains a twisted biphenyl system. It consists of four rings, A, B, C, D. The whole 
aporphines alkaloids are based on the 4H-diben[de,g]quinoline structure or its N-methyl 
derivative commonly known as the aporphine nucleus. It can be divided into three 
groups: 
[77-78]
 
a) The quaternary aporphines salts, for example N, N-dimethylhernovine 39 
b) The aporphines which contain N-methyl moeity, lirioferine 40, N-
methyllauroteanine 41 
c) The noraporphine, which possess a secondary nitrogen atom, eg: 
norlirioferine 42 
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1
H NMR 
[78]
 
 
The 
1
H NMR spectrum can provide important and valuable information leading 
to the structural elucidation of aporphines. The chemical shifts are very dependent on 
the position of the protons with respect to the aromatic rings. Several general features 
have been observed in the proton shifts of these alkaloids. The following chemical 
shifts have been observed. 
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Methoxyl group 
[79]
 
 
From the 
1
H NMR spectrum, the aromatic protons appeared at δ 6.3-8.2 and the 
methoxyl protons at δ 3.3-3.9. The most deshielded methoxyl protons are those 
attached to C-2, C-9 and C-10 and the most shielded at C-1, except when C-1 is 
substituted by a methylenedioxy group. Protons for methoxyl group attached to C-1 
usually appeared at high field due to the steric effect of ring D. 
 
The most downfield aromatic proton (H-11) was observed between δ 7.5 and 
8.2 depending on adjacent substituents at C-10. Substitution at C-10 will cause 
shielding of the H-11 proton. The most shielded aromatic proton is at C-3 and typically 
appeared as a singlet in the range of δ 6.5-7.5. The presence of a methoxyl group at C-
11 significantly affects the chemical shift of H-8 and H-9. If C-11 bears a hydroxyl 
group, the chemical shift of H-8 and H-9 because overlapped and thus no coupling was 
observed. The position of C-2 is also substituted when position of C-1 and C-11 are 
substituted. This affects the methoxyl groups at C-1 and C-11 that would be sterically 
hindered. As a result, the methoxyl protons are pushed out of the aromatic plane, into a 
shielded area. In addition, ring A and ring D is positioned facing each other. Hence the 
protons of the methoxyl groups can arrange themselves on top of the adjacent ring, 
which happens to be a shielded zone giving a more upfield shift. 
[79]
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Methylenedioxy group 
[77-78]
 
  
A methylenedioxy group usually shows resonances in the region of δ 5.87-6.02. 
The five possible locations for this group are C-1, 2; C-2, 3; C-9, 10; and C-10, 11. The 
presence of C-1, 2 methylenedioxy groups will cause an up field shift of the C-11 
proton which will appear in the range δ 7.47-7.86; the resultant twisted biphenyl system 
can induce magnetic nonequivalence between the methylene protons, which then 
appeared as doublets at δ 5.9 and 6.1.  
 
Protons for methylenedioxy group at C-9 and C-10 appear as a singlet whereas 
protons for those having methylenedioxy groups C-1 and C-2; C-2 and C-3; C-10 and 
C-11 appear as two doublets with coupling constant of about 1.5 Hz. This 
inequivalence arises from the torsion caused by the twisted biphenyl system of ring A 
and D. The appearance of the torsional effect on the methylenedioxy moiety depends 
on their positions and at position C-9, 10 the effect appears to be negligible. 
 
Aromatic protons 
[78]
 
 
The hydrogens at C-3, C-8 and C-9 of aporphine are located upfield between δ 
6.38-7.00 and cannot be easily differentiated from one another while hydrogen at C-11 
is found relatively downfield between δ 7.57-8.05. Nevertheless, H-3 normally 
resonates at a higher field compared to the other aromatic protons (δ 6.50-6.70) when it 
is ortho to a hydroxyl or a methoxyl. This is due to induction effect. On the other hand, 
H-11 usually resonates at a lower field with respect to the other protons due to the 
deshielding effect imposed by the facing aromatic ring A and hydrogen bonding with 
the C-1 substituent in ring A. 
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N-methyl group and aliphatic protons 
[78-79]
 
 
The N-methyl protons were typically observed at δ 2.4-2.8. The aliphatic 
protons of C-4, C-5 and C-7 displayed a complex resonance pattern with absorption in 
the region of δ 2.40-4.40 whereas methyl protons resonated in the region of δ 2.50-
2.60. A summary of the 
1
H NMR data of aporphine alkaloids are given in the Table 2.4. 
 
Table 2.4: 
1H NMR Data (δ/ppm) of Aporphine Alkaloids in CDCl3 
Position of 
substitution 
Methoxyl 
proton 
Methylenedioxy 
proton 
Aromatic 
proton 
N-methyl 
proton 
Aliphatic 
proton 
C-1 3.70-3.55     
C-2 4.12-3.75     
C-3      
C-8   7.00-6.38   
C-9 4.12-3.75  7.00-6.38   
C-10 4.12-3.75     
C-11 3.75-3.65  8.74-8.68   
C-1, 2  5.87-6.02    
C-2,3  5.87-6.02    
C-8, 9  5.87-6.02    
C-9, 10  5.87-6.02    
C-10, 11  5.87-6.02    
N-Me    2.50-4.44  
C-4     2.40-4.00 
C-5     2.40-4.00 
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13
C NMR 
[79]
 
 
The general characteristic of the different type of carbons are mentioned below. 
 
a) sp2 carbon bearing hydrogen: δ 105-112. 
b) sp2 carbons at position 1a, 1b, 3a, 7a and 11a: δ 119-130. 
c) sp3 carbons at position 4(δ 28-30), 7(δ 35) and 5 and 6a (about δ 42 and 53 
for noraporphine) and (about δ 53 and 62 for aporphine).  
d) Carbon of the substituents: N-methyl (about δ 43), methoxyl (δ 56-62) and 
methylenedioxy (δ 100). 
 
The quaternization of the N-atom causes deshielding of C-5 and C-6a and 
shielding of C-1b, C-3a, C-7 and C-7a. 
 
Mass Spectrometry 
[80]
 
 
 In the mass spectrum, the major fragmentation of the aporphine alkaloids is due 
to the loss of the hydrogen atom on C-6a. The [M-1]
+ 
peak always serves as the base 
peak of the molecule. If the molecule is substituted; [M-15]
+
, [M-17]
+
 and [M-31]
+ 
peak will also be observed due to the expulsion of a methyl, hydroxyl or methoxyl 
group respectively (Scheme 2.7). A hydroxyl group is substituted at ring D, a [M-17]
+
 
peak will be observed. 
 
Aporphine compound having the NH or N-CH3 groups will display peaks at [M-
29]
+ 
and [M-43]
+
 respectively which correspond to the lost of methylene imine group (-
CH2=NR) expelled via a retro Diels-Alder mechanism (Scheme 2.8) (or by the cyclic 
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process in ring B). The ion formed can further loose another methyl or methoxyl 
groupto produce peaks at [M-74]
+
, [M-58]
+
, [M-60]
+
, and [M-44]. 
[80]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.7: The Principle Mass Fragmentation of 
Aporphines. 
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R = H or CH3 
If R = H, peak observed is [M-29] 
+
 
If R = CH3, peak observed is [M-43] 
+
 
 
Scheme 2.8: The Mass Fragmentation of Aporphine with N-methyl or N-H Group. 
 
Ultraviolet spectrum 
[81]
 
 
The positions of the maximum absorptions in the ultraviolet spectra of 
aporphines depend mainly upon the location of the substituents. It is derived from the 
basic biphenyl system with the added influence of several auxochromes. The 
approximate absorption for various substitution patterns are listed as below. 
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           Position of substituents                             Absorption maximums (nm) 
1, 2 
 
234, 273, 312 
1, 2, 9 233, 280, 305 
 
1, 2, 10 226, 266, 275, 305 
 
1, 2, 11 220, 265, 272, 300 
 
1, 2, 9, 10 
 
220, 282, 305 
1, 2, 10, 11 220, 270, 305 
 
 
The shape of the curve and the density of the latter two maxima depend on the 
substitution in ring D. Furthermore, the monophenolic aporphine position at C-3 and C-
9 display a bathochromic shift at 315 nm and 350 nm in the alkaline environment. 
[81]
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2.8.3 Phenanthrene Alkaloid  
 
 
 
The phenanthrene alkaloids are derivatives of 1-(2-aminoethyl)phenanthrene. 
Even though they do not contain a nitrogen heterocycle, they are considered alkaloids 
because of their close relationship with aporphine alkaloids. Besides, they were found 
in the same plant families as aporphines, from which they are biogenetically derived, 
and they are usually included within the aporphinoids. Phenanthrene alkaloids with a 2-
(methylamino)ethyl side chain are 6,6a-secoaporphines, while those with a 2-
(dimethylamino)ethyl chain are often known as methines of the corresponding 
aporphine. 
[82]
 
 
Phenanthrene alkaloids are widely distributed and commonly co-occur with 
aporphine alkaloids. They are found in Menispermaceae, 
[83-84]
 Annonaceae, 
[85-87]
 
Ranuculaceae, 
[88]
 Fumariaceae, 
[82]
 Hernandiaceae, 
[89]
 and Lauraceae. 
[90-91]
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1
H-NMR 
  
The 
1
H-NMR spectra displayed the average chemical shifts of methoxyl groups 
of phenanthrene alkaloids which resonated at δ 3.9-4.1. One sharp peak attributed to 
three or six hydrogen group attached to nitrogen, was usually observed at δ 2.4-2.8. 
Methylenedioxyl protons show a peak at δ 6.0-6.3.  
 
As with aporphines, the C-5 proton appears quite upfield relative to the other 
aromatic protons which was observed at δ 9.3-9.6 in the 1H-NMR spectra. The presence 
of two doublets arising from the protons at C-9 and C-10 is a very characteristic feature 
of phenanthrene alkaloid skeleton. They appear close to each other at δ 7.3-7.9, with 
coupling constant of 9-10 Hz. The 2-aminoethyl side chain give rise to two batches of 
multiplets or doublet-doublet (J=15 Hz) at δ 3.2-3.6 and δ 2.6-3.0, each derived from 
two protons, which were typical of phenanthrene alkaloids for C-11 and C-12. 
[82]
 
 
Table 2.5 showed the examples of chemical shift of the 
1
H NMR of some 
phenanthrene alkaloids, i.e. glaucine methine 43, 
[86]
 and N-demethyl-2-
methoxyatherosperminine 21. 
[22]
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Table 2.5: 
1
H NMR (in CDCl3, ppm) for Some Phenanthrene Alkaloids. 
Position of H 43 21 
   
H-2 7.32 - 
H-5 9.30 9.53 
H-6 - 7.58 
H-7 - 7.53 
H-8 7.22 7.79 
H-9 7.80 7.67 
H-10 7.55 7.93 
H-11 3.30 3.43 
H-12 2.70 2.97 
2-OCH3 - 3.98 
3-OCH3 4.10 3.94 
4-OCH3 3.94 4.03 
6-OCH3 4.05 - 
7-OCH3 4.10 - 
N-CH3 2.40 2.58 
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13
C-NMR 
In the 
13
C-NMR spectra, the chemical shift of the methoxyl group appeared at δ 
60.0-61.0, whereas the N-methyl resonated at δ 42.0-43.0 and the chemical shift of sp2 
carbon bearing the hydrogen aromatic appeared at δ 120.0-128.0. Examples of 
chemical shift of phenanthrene alkaloids, Noruvariopsamine 44 
[93]
 and N-
methylatherosperminium cation 45 
[92]
 are shown in Table 2.6. 
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Table 2.6: 
13
C-NMR (in CDCl3, ppm) for Some Phenanthrene Alkaloids. 
Position of H 44 45 
C-1 130.7 129.2 
C-1a 125.5 125.5 
C-1b 124.1 124.3 
C-2 112.7 116.1 
C-3 151.0 150.8 
C-4 146.0 145.9 
C-5 113.0 122.1 
C-5a 121.5 132.4 
C-6 110.4 126.5 
C-7 149.2 126.5 
C-8 153.7 128.3 
C-8a 129.6 132.7 
C-9 121.4 127.4 
C-10 119.3 127.4 
C-11 31.0 26.2 
C-12 54.4 65.4 
3-OCH3 56.1 56.5 
4-OCH3 60.6 59.3 
7-OCH3 56.1 - 
8-OCH3 60.7 - 
N-CH3 36.2 52.3 
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Mass Spectrometry 
The mass of phenanthrene alkaloids are very informative regarding the nature of 
the side chains, which is the mode of cleavage of the amino group. The two 
fragmentations corresponding to loss of CH2NR1R2 and the CH2=N + R1R2 cation. This 
cation is usually the base peak and allows the identification of R1 and R2. Free bases 
and quaternary salts in this series generally undergo fragmentation beta to the nitrogen 
to generate a tropulium radiacal (a) and a mono-, di- or trimethylaminomethylene ion as 
the base peak (b). Thus, phenanthrenes with a 2-dimethylaminoethyl side chain present 
the base peak at 58 mass units, whereas those with a 2-monomenthylaminoethyl side 
chain show the base peak at 44 mass units. 
[82, 86]
 The mass fragmentation pattern is 
given in Scheme 2.9. 
 
 
 
Scheme 2.9. The Mass Fragmentation of Phenanthrene Alkaloid
  
 
 
 
 
 
 
CHAPTER 3 
 
 
RESULTS AND 
DISCUSSIONS 
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3.0 RESULTS AND DISCUSSIONS 
 
3.1 Chemical Constituents in Crytocarya nigra (Lauraceae) 
 
Alkaloids from the bark and leaves of this species were extracted by the general 
procedure as described in the experimental section in Chapter 5.  
 
The dichloromethane extract obtained were subjected through extensive column 
chromatography (CC) and by preparative thin layer chromatography (PTLC). Four 
alkaloids (N-methylisococlaurine 46, atherosperminine 11, 2-hydroxyatherosperminine 20, 
and noratherosperminine 47) were isolated from the bark and three alkaloids (isocorydine 
48, norisocorydine 49, argentinine 50) with one non-alkaloidal aromatic compound 
(benzamide 51) were afforded from the leaves of Crytocarya nigra.  
 
The following subchapter shall discuss briefly and concisely on the structural 
elucidation of each compounds isolated. 
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3.1.1   N-Methylisococlaurine 46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                    46 
 
N-Methylisococlaurine 46 was isolated as a brownish amorphous solid with 
[α]  = +29.4º (c 1.0, MeOH). The UV spectrum showed absorption bands at 301 nm. 
The IR spectrum (Figure 3.3) of this alkaloid showed strong absorption peak at 3266 
and 2921 cm
-1
 indicated the presence of hydroxyl group and stretching of C-H aromatic, 
respectively 
[94]
. The LCMS spectrum (Figure 3.2) of compound 46 showed a 
pseudomolecular ion peak at m/z 300.16, [M+H]
+ 
corresponding to the molecular 
formula C18H21NO3, with nine degrees of unsaturation (3 rings and 6 double bonds). 
 
The 
1
H NMR spectrum (Figure 3.4) revealed six aromatic proton signals at the 
low field region. There were two singlets at δ 6.34 and δ 6.21 attributable to H-5 and H-
8 respectively. Two signals centered at δ 6.78 (d, J=8.5, H-2’ and H-6’) and δ 6.50 (d, 
J=8.5, H-3’ and H-5’) appeared as doublets. The 1H NMR spectrum exhibited one 
methoxyl group and one N-methyl group at δ 3.82 and δ 2.42 respectively each 
appearing as a singlet. Furthermore, a total of seven proton signals were observed at a 
A B 
C 
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higher region between δ 2.76-3.66 attributable to the aliphatic protons of H-αa, H- αb, H-
1, H-3a, H-3b, H-4a and H-4b. In fact, the correlation of vicinal protons H-αa/H-αb, H-
2’/H-3’, H-5’/H-6’ and H-3/H-4 were observed in the COSY spectrum (Figure 3.7). The 
complete assignments for the proton and carbon signals are tabulated in Table 3.1 and 
1
H-
1
H and 
1
H-
13
C coupling pattern are shown in Figure 3.1. 
 
The 
13
C NMR spectrum (Figure 3.5) is in agreement with the molecular formula 
deduced from the mass spectrum, accounting for all 18 carbons. While the DEPT 135 
spectrum (Figure 3.6) showed there are one methoxyl, one N-methyl, three methylenes, 
seven methines, and six quaternary carbons in the molecule skeleton. The highest field 
signal in the 
13C spectra was observed at δ 64.83 can be assigned to C-1, meanwhile two 
overlapping signals appeared at δ 130.4 and δ 115.5 corresponded to C-2’/C-6’ and C-
3’/C-5’ respectively. The HMQC spectrum (Figure 3.8) displayed the cross-peaks of H-
5/C-5 and H-8/C-8 at δH 6.34/ δC 110.8 and δH 6.21/ δC 113.9 ppm respectively. 
 
The HMBC spectrum (Figure 3.9) revealed correlation H-5 to H-7 and H-8a, 
further supported the position of OMe group at C-7. In addition, the correlations of H-2’ 
and H-6’ to the carbon bearing hydroxyl group, C-4’, were also observed. Another 
hydroxyl position at C-6 was deduced through correlation of H-8 to C-6, C-1 and C-4a. 
Long range coupling of H-5 to one of the C-4 protons is clearly seen in the HMBC 
spectrum. 
 
Finally, assignment of all proton and carbon signals were established by DEPT, 
COSY, HMQC and through analysis of HMBC spectra and also by comparison with 
literature value 
[94,95]
 and thus confirmed the structure of N-Methylisococlaurine 46. 
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Figure 3.1: 
1
H-
1
H and 
1
H-
13
C Coupling Pattern Observed in COSY and HMBC Spectra 
of N-methylisococlaurine 46 
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Table 3.1: 
1
H NMR (in CDCl3, 400 MHz), 
13
C NMR (in CDCl3, 400 MHz), HMBC and 
HMQC of 46 and comparison with 
1
H NMR literature values (Saidi et al. 2011) 
 
Position δH, ppm (J in 
Hz) 
(observed) 
δC (ppm) 
(observed) 
HMBC 
(H→C) 
HMQC δH, ppm (J in Hz) 
(Saidi et al., 2011) 
 
1 
 
3.63-3.66, t, 
J=6.5 
 
64.8 
 
α, 3, 8a 
 
H-1 
 
3.67-3.79, t 
3 Ha: 2.96-3.01, m 
Hb: 2.52-2.65, m 
44.6 - H-3 Ha: 2.98-3.03, dd 
Hb: 2.74-2.77, m 
4 Ha: 2.52-2.65, m 
Hb: 2.25-2.40, m 
24.7 3, 4a, 8a H-4 Ha: 3.17-3.24, m 
Hb: 2.53-2.60, m 
4a - 125.2 - - - 
5 6.34, d, J=2.2 110.8 4, 8a, 7 H-5 6.51, s 
6 - 145.3 - - - 
7 - 143.5 - - - 
8 6.21, s 113.9 1, 6, 4a H-8 6.29, s 
8a - 130.1 - - - 
α αa: 2.77-2.83, dd 
αb: 2.52-2.65, m  
J=14.4, 6.5 
40.8 8a, 2’, 6’ H-α 2.80-2.86, m 
1’ - 131.1 -  - 
2’ 6.78, d, J=8.5 130.4 α, 4’, 6’ H-2’ 6.86-6.88, d, J=8.3 
3’ 6.50, d, J=8.5 115.5 1’, 5’  6.54-6.56, d, J=8.3 
4’ - 154.6 - - - 
5’ 6.50, d, J=8.5 115.5 1’, 5’ H-5’ 6.54-6.56, d, J=8.3 
6’ 6.78, d, J=8.5 130.4 α, 6’, 4’ H-6’ 6.86-6.88, d, J=8.3 
7-OMe 3.82, s 55.9  - 3.74, s 
N-Me 2.42, s 42.3 1 - 2.37, s 
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Figure 3.2: LCMS Spectrum of N-methylisococlaurine 46 
[M+H]
+
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3266.30 
Figure 3.3: IR Spectrum of N-methylisococlaurine 46 
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Figure 3.4: 
1
H NMR Spectrum of N-methylisococlaurine 46 
 
Phenolic 
proton 
3a 
 a 
3b, b,  
4a 
4b 
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Figure 3.5: 
13
C NMR Spectrum of N-methylisococlaurine 46 
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Figure 3.6: 135 DEPT NMR Spectrum of N-methylisococlaurine 46 
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Figure 3.7: COSY Spectrum of N-methylisococlaurine 46 
 
 
H-/H-1 
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Figure 3.8: HMQC Spectrum of N-methylisococlaurine 46 
 
3 

4 
4 
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Figure 3.9: HMBC Spectrum of N-methylisococlaurine 46
4 
3 

4 
H-3/C-3 
H-3/C-4a 
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3.1.2   Atherosperminine 11 
 
 
 
 
 
 
 
 
             11 
 
Atherosperminine 11 was isolated as brownish amorphous solid. Its UV 
spectrum exhibited absorption bands at 217, 227, 256, 306 and 345 nm.
[96]
 The IR 
spectrum showed absorption at 1600 cm
-1
 indicated the stretching of aromatic C=C. The 
LCMS spectrum (Figure 3.11) revealed a pseudomolecular ion peak, [M+H]
+
 at m/z 
310.18 suggesting a molecular formula of C20H23NO2 with 10 degree of unsaturation. 
 
The 
1
H-NMR spectrum (Figure 3.12) displayed 7 proton signals in the aromatic 
region including a doublet that belong to H-5 at δ 9.67 which represented typical 
characteristic of phenanthrene type. There were overlapping signals of doublet and 
doublet of doublets (dd) observed in the region δ 7.84-δ 7.87 which were assignable to 
H-10 and H-8. This spectrum also displayed a multiplet signal attributable to H-9, H-7 
and H-6 which were present at δ 7.56- δ 7.64. In addition, a singlet peak at δ 7.25 
belonged to proton H-2. 
The 
1
H-NMR spectrum (Figure 3.12) also showed the presence of two methoxyl 
groups at δ 4.04 and δ 3.92 observed as a singlet. One sharp singlet attributable to six 
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protons attached to nitrogen was observed at δ 2.41. Furthermore, two sets of multiplets 
were present at δ 3.26-3.34 and δ 2.65-2.70, which were assigned to the methylene 
protons H-11 and H-12 respectively. 
 
The 
13
C-NMR spectrum (Figure 3.13) revealed the presence of 20 carbon atoms 
which validated the molecular formula, C20H23NO2. The spectrum showed the presence 
of two N-methyl signals, two methoxyls, two methylenes, seven methines, and seven 
quaternary carbons. The signals of N-methyl was observed at δ 45.6, while two methoxy 
carbon resonated at δ 56.7 and δ 59.9 which correspond to C-3 and C-4 respectively. 
Carbon in aromatic regions resonated at lower chemical shifts, δ 114.8, δ 122.5, δ 125.8, 
δ 126.6, δ 126.6 and δ 128.2 may belong to C-2, C-10, C-7, C-6, C-9 and C-5/C-8, 
whereas the signals of substituted aromatic carbon atoms were observed at higher 
chemical shift for C-3 and C-4 at δ 150.9 and δ 146.0 respectively. The higher chemical 
shift carbons were affected by the presence of electronegative substituents effect. The 
methylene carbon for C-11 and C-12 were observed at δ 32.6 and δ 61.1 typical for 
methylene position. 2D NMR experiments (COSY, HMQC, and HMBC) allowed the 
complete assignments of the protons and carbons chemical shift. 
 
The COSY spectrum (Figure 3.14) showed the correlations of vicinal proton 
between H-5/H-6, H-7/H-8, H-9/H-10 and H-11/H-12. In the HMBC spectrum (Figure 
3.16) showed long range heteronuclear interaction between N-CH3/C-12, H-12/C-11, 
H-11/C-2 and C-1a and H-5/C-1b and C-8a. Other COSY and HMBC correlations are 
summarized in Figure 3.10 and Table 3.2. The assignments of the protons and carbons 
were consistent with literature reviews 
[82,96]
 and thus confirmed the structure of 
atherosperminine 11. 
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Figure 3.10: 
1
H-
1
H and 
1
H-
13
C Coupling Pattern Observed in COSY and HMBC 
Spectra of Atherosperminine 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 70 
 
 
Table 3.2: 
1
H NMR (in CDCl3, 400 MHz), 
13
C NMR (in CDCl3, 100 MHz), and HMBC 
of 11 and Comparison with 
1
H NMR Literature Values (Kini et al. 2004). 
 
Position δH, ppm (J in Hz) 
(observed) 
δC (ppm) HMBC 
(H→C) 
δH, ppm (J in Hz) 
(Kini et al., 2004) 
 
1 
 
- 
 
130.2 
 
- 
 
- 
1a - 126.2 - - 
1b - 125.3 - - 
2 7.25, s 114.8 1, 1a, 3, 4, 
11 
7.20-7.50, m 
3 - 150.9 - - 
4 - 146.0 - - 
5 9.67, d, J=8.6 128.2 6, 8a 9.67, m 
5a - 132.9 - - 
6 7.56-7.64, m  126.6 5a, 7 7.20-7.50, m 
7 7.56-7.64, m 125.8 5, 8, 8a 7.20-7.50, m 
8 7.84-7.86, dd,  
J1=7.3, J2=2.0 
128.2 6, 8a, 9 7.65, m 
8a - 133.3 - - 
9 7.56-7.64, m 126.6 1b, 10 7.65, m 
10 7.86, d, J=9.3 122.5 8a, 1b 7.65, m 
11 3.26-3.34, m 32.6 1, 1a, 12 2.30-3.85, m 
12 2.65-2.70, m 61.1 1, 11, N-CH3 2.30-3.85, m 
3-OMe 4.04, s 56.7 3 3.90, s 
4-OMe 3.92, s 59.9 4 3.88, s 
2 N-Me 2.41, s 45.6 11, 12 2.25, s 
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Figure 3.11: LCMS Spectrum of Atherosperminine 1
[M+H]
+
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Figure 3.12: 
1
H NMR Spectrum of Atherosperminine 11 
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Figure 3.13: 
13
C NMR Spectrum of Atherosperminine 11 
 
 
C-2 
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Figure 3.14: COSY Spectrum of Atherosperminine 11 
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Figure 3.15: HMQC Spectrum of Atherosperminine 11 
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Figure 3.16: HMBC Spectrum of Atherosperminine 11 
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3.1.3   2-hydroxyatherosperminine 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
2-Hydroxyatherosperminine 20 was obtained as a brownish amorphous solid. 
The IR spectrum (Figure 3.18) revealed an important peak at 3412 cm
-1
 indicated to the 
presence of hydroxyl group. Its UV spectrum exhibited absorption bands at 296 and 286 
nm. The LCMS spectrum (Figure 3.17) showed a pseudomolecular ion peak at m/z 
326.18, [M+H]
+ 
corresponding to the molecular formula C20H23NO3, with 10 degrees of 
unsaturation (3 rings and 7 double bonds). The peak at m/z 651.34973 may be 
considered as an artefact from LC-MS analysis; (325+325+1 = 651) which commonly 
appeared and many at times wrongly mistaken as a dimer. If it is a dimer, the molecular 
weight should be (M+M)-2, due to loss of two hydrogen from the formation of a bond 
rather than (M+M+1) as observed in this case.   
 
Similar features were observed on 
1
H-NMR and 
13
C-NMR spectra of 
compounds 11 and 20, which confirmed a close structural relationship between both 
compounds. However, there was obvious differences in the 
1
H-NMR spectrum of 
compound 20, the H-2 proton signal at δ 7.25 which was apparent in compound 11  was 
absent in compound 20, due to the presence of OH group at C-2 position.  
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In the 
1
H-NMR (Figure 3.19), there were two distinct methoxy signals appeared 
as a singlet at δ 3.90 and δ 4.02, most probably attached to C-4 and C-3 respectively. 
One sharp peak attributed to the six methyl hydrogen groups attached to the nitrogen 
was observed at δ 2.51. In addition, a very downfield chemical shift was observed at δ 
9.64 (d, J=8.2 Hz), a characteristic of H-5 of phenantrene type. A doublet signal 
appeared at δ 7.83 (d, J=9.28) corresponded to two aromatic protons belong to H-8 and 
H-10. The remaining of the aromatic protons gave a series of multiplet corresponding to 
three protons at δ 7.55-7.63 for H-9, H-6 and H-7. This proved that the ring D was not 
substituted. Finally, four aliphatic protons were observed at δ 3.36-3.40 and δ 2.80-2.84 
as multiplets which were typical of the phenantrene H-11 and H-12 methylene adjacent 
to N atom. 
 
The 
13
C-NMR spectrum (Figure 3.20) showed the presence of two N-methyl 
signals, two methoxyl groups, two methylenes, six methines and eight quaternary 
carbons. The proton-proton correlations were determined using COSY experiment. 
COSY spectrum (Figure 3.21) displayed correlations of vicinal proton between H-11/H-
12, H-10/H-9 and H-8/H-7. Due to the limitation of the sample amount, we were unable 
to get its 2D NMR spectrum including HMBC & HMQC spectrum. 
The spectral data obtained were consistent with those found in the literature 
values 
[22]
, thus confirming the presence of 2-hydroxyatherosperminine 20. 
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Table 3.3: 
1
H NMR (in CDCl3, 400 MHz) and 
13
C NMR (in CDCl3, 400 MHz) of 20 and 
Comparison with Literature Values (Awang et al. 2008) 
 
Position δH, ppm (J in Hz) 
(observed) 
δC (ppm) 
(observed) 
δH, ppm (J in Hz) 
(Awang, 2008) 
δC (ppm) 
(Awang, 
2008) 
 
1 
 
- 
 
121.2 
 
- 
 
120.9 
1a - 125.9 - 125.2 
1b - 115.6 - 120.8 
2 - 146.8 - 144.4 
3 - 151.1 - 145.5 
4 - 132.7 - 141.7 
5 9.64, d, J=8.3 126.9 9.31-9.32, d, 
J=7.32 
126.6 
5a - 130.0 - 132.1 
6 7.54-7.62, m  126.8 7.47-7.52, m 126.5 
7 7.54-7.62, m 127.9 7.47-7.52, m 126.9 
8 7.81-7.83, m,   
 
128.1 7.83-7.85, dd,  
J1=7.80, J2=1.72 
128.4 
8a - 128.3 - 128.8 
9 7.62, d, J=9.2 127.0 7.68-7.71, d, 
J=9.04 
126.8 
10 7.83, d, J=9.2 125.5 7.95-7.98, d, 
J=9.04 
121.9 
11 3.36-3.40, m 22.7 3.61, m 21.5 
12 2.80-2.84, m 56.7 3.04, m 57.7 
3-OMe 4.02, s 59.9 4.04, s 61.2 
4-OMe 3.90, s 57.2 3.84, s 60.3 
2 N-Me 2.51, s 29.7 2.80, s 43.0 
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Figure 3.17: LCMS Spectrum of 2-hydroxyatherosperminine 20 
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Figure 3.18: IR Spectrum of 2-hydroxyatherosperminine 20 
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Figure 3.19: 
1
H NMR Spectrum of 2-hydroxyatherosperminine 20 
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Figure 3.20: 
13
C Spectrum of 2-hydroxyatherosperminine 20 
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Figure 3.21: COSY Spectrum of 2-hydroxyatherosperminine 20 
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3.1.4   Noratherosperminine 47 
 
 
 
 
 
 
 
 
      47 
 
Noratherosperminine 47 was obtained as brownish amorphous solid. Its UV 
spectrum exhibited absorption bands at 258, 308 and 347 nm. The IR spectrum (Figure 
3.23) gave absorption bands for aromatic ring (2917 and 2849 cm
-1
) and another band at 
3363 cm
-1
 indicated the N-H stretching 
[97]
. The LCMS spectrum (Figure 3.22) revealed 
a pseudomolecular ion peak, [M+H]
+
 at m/z 296.16 suggesting a molecular formula of 
C19H21NO2 with 10 degree of unsaturation (3 rings and 7 double bonds). 
 
The structure of 47 was mainly deduced from the 
1
H-NMR spectrum (Figure 
3.24). The 
1
H-NMR and 
13
C-NMR spectra features were also similar to those of 
atherosperminine 11 except the absence of one N-methyl group. The two methoxyl 
groups resonated at δ 4.01 and δ 3.90 as a singlet each which belongs to C-3 and C-4, 
respectively. One methyl proton attached to nitrogen atom was observed at δ 2.48. 
Furthermore, two sets of triplets were present at δ 3.32 and δ 2.99, which were 
assignable to the methylene protons H-11 and H-12 respectively. 
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There were 7 proton signals at the aromatic region were displayed in the 
1
H-
NMR spectrum including a doublet belong to H-10 (δ 7.87), and a doublet of doublet 
belong to H-8 (δ 7.81-7.83). A downfield chemical shift was observed as a doublet at δ 
9.64 with a coupling constant of 7.6 Hz typical of H-5. A multiplet signal was also 
present at δ 7.54-7.60 which assignable for H-9, H-6, H-7 and H-2. 
 
The 
13
C-NMR spectrum (Figure 3.25) revealed the presence of 19 carbon atoms 
which validated the molecular formula, C19H21NO2. The spectrum showed the presence 
of one N-methyl signal, two methoxyls, two methylenes, seven methines, and seven 
quaternary carbons. The signals of two methoxy carbons resonated at δ 51.5 and δ 56.7 
which correspond to C-3 and C-4 respectively while N-methyl was observed at δ 34.4. 
The signals of substituted aromatic carbon atoms were observed at higher chemical shift 
for C-3 and C-4 at δ 151.0 and δ 146.4 respectively. The higher chemical shift carbons 
were affected by the presence of electronegative substituents effect. The methylene 
carbon for C-11 and C-12 were observed at δ 32.1 and δ 59.9 typical for methylene 
position.  
 
The COSY spectrum (Figure 3.26) showed the correlations of vicinal proton 
between H-11/H-12, H-10/H-9 and H-5/H-6. Based on the available spectral data and 
investigation of the literature reviews 
[82,97]
, thus confirmed the structure of 
noratherosperminine 47. 
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Table 3.4: 
1
H NMR (in CDCl3, 400 MHz) and 
13
C NMR (in CDCl3, 400 MHz) of 47 and 
Comparison with 
1
H NMR Literature Values of (Leboeuf et al. 1980).  
 
Position δH, ppm (J in Hz) 
(observed) 
δC (ppm) 
(observed) 
δH, ppm (J in Hz) 
(Leboeuf, 1980) 
 
1 
 
- 
 
130.2 
 
- 
1a - 126.8 - 
1b - 128.1 - 
2 7.54-7.60, m 115.4 7.21, s 
3 - 151.0 - 
4 - 146.4 - 
5 9.64, d, J=7.6 128.3 9.63, m 
5a - 130.2 - 
6 7.54-7.60, m  128.3 7.45-7.93, m 
7 7.54-7.60, m  128.3 7.45-7.93, m 
8 7.81-7.83, dd,  
J1=7.3, J2=1.9 
128.3 7.45-7.93, m 
8a - 132.8 - 
9 7.54-7.60, m 128.2 7.45-7.93, m 
10 7.87, d, J=9.3 122.0 7.45-7.93, m 
11 3.32, t, J=7.1 32.1  
12 2.99, t, J=7.1 59.9  
3-OMe 4.01, s 51.5 3.99, s 
4-OMe 3.90, s 56.7 3.90, s 
 N-Me 2.48, s 34.4 2.51, s 
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Figure 3.22: LCMS Spectrum of Noratherosperminine 47 
 
[M+H]
+
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Figure 3.23: IR Spectrum of Noratherosperminine 47 
N-H 
stretching 
 90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24: 
1
H-NMR Spectrum of Noratherosperminine 47 
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Figure 3.25: 
13
C-NMR Spectrum of Noratherosperminine 47 
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Figure 3.26: COSY Spectrum of Noratherosperminine 47 
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3.1.5   Isocorydine 48 
  
 
 
 
 
 
 
 
           48 
 
Isocorydine 48 was obtained as brownish amorphous powder with  +196º 
(c = 0.10, MeOH) indicated the absolute configuration at C-6a was S as in the known 
alkaloid 
[98]
. Its UV spectrum exhibited absorption bands at 270 and 310 nm, which 
indicated the existence of the conjugated system. The IR spectrum revealed absorption 
band due to the highly conjugated hydroxyl group at 3202 cm
-1
. The LCMS spectrum 
(Figure 3.27) revealed a pseudomolecular peak at m/z 342.2 suggesting a molecular 
formula of C20H24NO4 with 10 degree of unsaturation (4 rings and 6 double bonds). 
 
The 
1
H-NMR spectrum (Figure 3.28) established the presence of three methoxyl 
groups at δ 3.89, 3.88, and 3.68 which appeared as a singlet, corresponding to 10-OMe, 
2-OMe, and 1-OMe respectively. H-3 was observed as a singlet at δ 6.68 indicating that 
C-1 and C-2 in ring A are substituted with methoxyl groups. Another peak presence as 
singlet at δ 2.50 corresponded to N-Me group in ring B. In addition, vicinal protons H-8 
and H-9 signals appeared as a doublet at δ 6.81 and 6.84 with a coupling constant of 8.3 
Hz. The aliphatic proton, H-5 appeared at deshielded area (δ 2.97-3.04) compared to H-
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4 (δ 2.45-2.49) due to the withdrawing effect of the neighboring electronegative N-
atom.  
 
The 
13
C-NMR (Figure 3.29) and DEPT (Figure 3.30) spectra for Compound 48 
showed 20 carbon signals consisting of four methyls, three methylenes, four methines 
and nine quaternary carbon signals. Three signals observed at δ 62.1, 56.1 and 55.9 
corresponded to the OMe group attached to C-1, C-10 and C-2 respectively. The signals 
for quaternary carbons at δ 151.3, 149.5, 144.0, and 142.2 could be assigned to C-2, C-
10, C-11 and C-1 respectively. 
 
The COSY spectrum (Figure 3.31) showed cross peaks between CH2-5/ CH2-4, 
and CH2-7/ CH-6a. An analysis of HMBC spectrum (Figure 3.33) revealed significant 
cross-peaks of H-9 to C-11 which bearing a hydroxyl group. The correlation of protons 
10-OMe and H-8 to C-10 were also observed in the HMBC spectrum.  
 
The spectral data obtained were consistent with those found in the literature 
reviews, thus confirming the structure for isocorydine 48 
[98-100]
. 
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Table 3.5: 
1
H NMR (in CDCl3, 400 MHz), 
13
C NMR (in CDCl3, 400 MHz) and HMBC 
of 48 and Comparison with 
1
H NMR Literature Values (Ferreira et al. 2010). 
 
Position 
δH, ppm (J in Hz) 
(observed) 
δC 
(ppm) 
HMBC 
(H→C) 
δH, ppm (J in Hz) 
(Ferreira, 2010) 
 
1 
 
- 
 
142.2 
 
- 
 
- 
1a - 125.9 - - 
1b - 129.2 - - 
2 - 151.3 - - 
3 6.68, s 111.0 4,2,1,1b 6.63, br s 
3a - 130.0 - - 
4 2.45-2.49, m 29.3 1b,3a,3,5 4β: 2.64, ddt, 
J=16.5,3.5,1.3 
4α: 3.11, ddddd, 
J=16.5,12.1,5.5,1.3,1.0   
5 2.97-3.04, m 52.7 4 5β: 2.41, ddd, 
J=12.1,11.3,3.5 
5α: 2.94, ddd, 
J=11.3,5.5,1.3 
6a 3.11-3.20, m 62.9 3a 6aα: 2.80, ddt, 
J=13.2,3.5,1.3 
7 2.66-2.71, dd, 
J1=16.6, J2= 3.2 
35.9 1b,8 7β: 2.37, ddd, 
J=13.2,13.0,1.0 
7α: 2.97, dd, J=13.0,3.5 
7a - 130.2 - - 
8 6.81, d, J=8.3 119.0 7,11a,10 6.76, dd, J=8.0,1.0 
9 6.84, d, J=8.3 111.1 7a,11 6.79, d, J=8.0 
10 - 149.5 - - 
11 - 144.0 - - 
11a - 120.2 - - 
1-OMe 3.68, s 62.1 1,2-OMe 3.64, s 
2-OMe 3.88, s 55.9 2,1-OMe 3.84, s 
10-OMe 3.89, s 56.1 10 3.85, s 
N-Me 2.50, s 43.9 5,6a 2.46, br s 
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Figure 3.27: LCMS Spectrum of Isocorydine 48 
 
 
 
[M+H]
+
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Figure 3.28: 
1
H NMR Spectrum of Isocorydine 48 
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Figure 3.29: 
13
C NMR Spectrum of Isocorydine 48 
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Figure 3.30: DEPT Spectrum of Isocorydine 48 
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Figure 3.31: COSY Spectrum of Isocorydine 48 
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Figure 3.32: HMQC Spectrum of Isocorydine 48 
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Figure 3.33: HMBC Spectrum of Isocorydine 48
 103 
 
3.1.6   Norisocorydine 49 
 
 
49 
 
Norisocorydine 49 was isolated as brownish amorphous powder with  
+158.5º (c = 0.10, EtOH) indicated the absolute configuration at C-6a was S as in the 
known alkaloid 
[99-101]
. Its UV spectrum exhibited maxima at 270 and 310 nm, which 
supported a 1, 2, 10, 11-tetrasubstitued aporphine skeleton 
[102]
. In addition, the IR 
spectrum gave a broad absorption bands between 3500 and 2936 cm
-1
 due to the 
presence of OH and NH groups. The LCMS spectrum revealed a pseudomolecular peak 
at m/z 328.2 suggesting a molecular formula of C19H22NO4 with 10 degree of 
unsaturation (4 rings and 6 double bonds). Other peak was observed at m/z 350.2 
[M+23]
+
, due to the addition of sodium, Na.  
 
The 
1
H-NMR and 
13
C-NMR spectra of compound 49 were almost similar to the 
compound 48, which confirmed a close structural relationship between both 
compounds. However, the only factor which differentiates compound 49 with 
compound 48 was the absence of an N-methyl signal at δ 2.50 in the 1H-NMR spectrum 
(refer Figure 3.35). 
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The 
13
C-NMR (Figure 3.36) and DEPT (Figure 3.37) spectra for compound 49 
showed 19 carbon signals. The DEPT spectrum showed three methyls, three 
methylenes, four methines and nine quartenary carbon signals. Three signals of 
methoxyl group were observed at δ 62.3, 56.2 and 56.0 belong to OMe group at C-1, C-
10 and C-2 respectively. The signals for quaternary carbons appeared at δ 151.5, 149.5, 
144.2, and 142.1 which were assigned to C-2, C-10, C-11 and C-1 respectively. 
 
In the COSY spectrum (Figure 3.38), the presence of methylene protons at 
position C-4 (δ 2.67-2.72, δ 2.95-3.04) and C-5 (δ 2.89-2.95, δ 3.29-3.33) were 
observed. An analysis of HMBC spectrum (Figure 3.40) revealed cross-peaks between 
the methylene protons and the methine protons with a quaternary carbon at δ 130.4 (C-
3a) and δ 129.9 (C-1b). Thus, with this observation, the exact position of quaternary 
carbons could be determined. The other interaction of HMBC coupling pattern are 
summarized in Table 3.6.  
 
The spectral data obtained were consistent with those found in the literature 
reviews, thus confirming the structure for norisocorydine 49 
[99-101]
. 
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Table 3.6: 
1
H NMR (in CDCl3, 400 MHz), 
13
C NMR (in CDCl3, 400 MHz), and HMBC 
of 49 and Comparison with 
1
H NMR Literature Values (Chang et al. 2001). 
 
Position δH, ppm (J in Hz) 
(observed) 
δC (ppm) HMBC 
(H→C) 
δH, ppm (J in Hz) 
(Chang, 2001) 
 
1 
 
- 
 
142.1 
 
- 
 
- 
1a - 125.8 - - 
1b - 129.9 - - 
2 - 151.5 - - 
3 6.69, s 111.8 1,1b,2,4 6.90, s 
3a - 130.4 - - 
4 α, 2.67-2.72, m 
β, 2.95-3.04, m 
29.4 1b,3,5  
5 α, 2.89-2.95, m 
β, 3.29-3.33, m 
42.9 4,6a  
6a 3.57-3.65, m 54.2 3a 3.63, d, J=3.6 
7 α, 2.53, t, J=13.2 
β, 2.72-2.77, dd, 
J=13.2,4.2 
38.5 1b,6a,7a,8,11a  
7a - 130.5 - - 
8 6.79, d, J=8.1 119.0 7,11a 6.87, d, J=8.4 
9 6.83, d, J=8.1 111.0 11 6.95, d, J=8.4 
10 - 149.5 - - 
11 - 144.2 - - 
11a - 120.2 - - 
1-OMe 3.69, s 62.3 1,2-OMe 3.67, s 
2-OMe 3.89, s 56.0 10 3.90, s 
10-OMe 3.89, s 56.2 2,1-OMe 3.87, s 
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Figure 3.34: LCMS Spectrum of Norisocorydine 49 
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Figure 3.35: 
1
H NMR Spectrum of Norisocorydine 49 
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Figure 3.36: 
13
C NMR Spectrum of Norisocorydine 49 
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Figure 3.37: DEPT Spectrum of Norisocorydine 49 
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Figure 3.38: COSY Spectrum of Norisocorydine 49 
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Figure 3.39: HMQC Spectrum of Norisocorydine 49
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Figure 3.40: HMBC Spectrum of Norisocorydine 49
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3.1.7   Argentinine 50 
 
 
 
 
 
 
      50 
 
Argentinine 50 was isolated as brownish amorphous solid. Its UV spectrum showed 
absorption bands at 245, 256, 291, and 345 nm. The IR spectrum exhibited strong and 
broad O-H stretching at 3367 cm
-1
 and a strong C-H stretching for aromatic ring at 2922 
and 2852 cm
-1
.  The LCMS spectrum revealed a pseudomolecular ion peak,[M+H]
+
 at m/z 
296 suggesting a molecular formula of C19H21NO2 with 10 degree of unsaturation (3 rings 
and 7 double bonds). 
 
The 
1
H-NMR spectrum (Figure 3.42) indicated the presence of singlets at δ 2.41 
(6H) and δ 3.76 (3H), which corresponded to two N-methyl groups and methoxyl groups. 
In the aromatic region, two coupled protons at δ 7.56 (1H, d, J=9.4 Hz) and δ 7.82 (1H, d, 
J=9.4 Hz), characteristic of an AB system corresponding to H-9 and H-10 in the 
phenanthrene ring system, were detected. The aromatic proton at δ 9.34 (1H, d, J=7.6 Hz) 
corresponded to the H-5 in the phenanthrene alkaloids. This signal was consistent with the 
presence of a methylenedioxy group at C-3 and C-4 that resulted in an upfield shift of the 
H-5 proton signals to ≈ δ 9.0, since phenanthrene alkaloids with methoxy and/or hydroxyl 
substituents at C-3 and C-4 show H-5 signal downfield between δ 9.3 and δ 9.9.  Finally, 
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two sets of multiplets were observed at δ 3.22-3.26 and δ 2.62-2.80, which were assignable 
to the methylene proton H-11 and H-12 respectively. 
 
Comparison of the UV, IR, LCMS and 
1
H-NMR data of compound 50 with 
previous reported literature, thus confirming the structure for argentinine 50 
[103]
. 
 
Table 3.7: 
1
H NMR (in CDCl3, 400 MHz) of 50 and Comparison with 
1
H NMR Literature 
Value (Javier et al. 2002). 
 
Position δH, ppm (J in Hz) 
(observed) 
δH, ppm (J in Hz)  
(Javier, 2002) 
 
1 
 
- 
 
- 
1a - - 
1b - - 
2 7.17, s 7.28, s 
3 - - 
4 - - 
5 9.34, d, J=7.6 9.42, br d, J=9.2 
5a - - 
6 7.52-7.58, m  7.86, br d, J=9.2 
7 7.52-7.58, m  7.61, t d, J=8.4, 1.6 
8 7.78-7.82, m 7.53, br d, J=8.8 
8a - - 
9 7.56, d, J=9.4 7.68, d, J=9.2 
10 7.82, d, J=9.4 7.91, d, J=9.2 
11 3.22-3.26, m 3.21, ddd, J=16.8, 11.6, 5.2 
12 2.62-2.80, m 3.59, ddd, J=16.8, 11.6, 5.2 
4-OMe 3.76, s 3.84, s 
2 N-Me 2.41, s 2.84, s 
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Figure 3.41: LCMS Spectrum of Argentinine 50 
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Figure 3.42: 
1
H-NMR Spectrum of Argentinine 50
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3.1.8   Benzamide 51 
 
 
 
 
 
            51 
Benzamide 51 was the major compound isolated from the leaves of Cryptocarya 
nigra and obtained as crystalline needles with melting point 125-127ºC. Compound 51 
showed UV absorption at 294 and 280 nm. In addition, the IR spectrum exhibited a 
strong absorption peak at 1646 cm
-1
 attributed to a conjugated ketone function. The 
binding of NH2 in the structure was indicated by the peak at 3368 cm
-1
. The mass 
spectrum (Figure 3.43) showed a molecular ion at m/z 121 consistent with molecular 
formula C7H7NO. Other significant peaks were observed at m/z 105 [M-16]
+ 
(base 
peak) and 77 [M-44]
+
, due to the loss of NH2 and CONH2, respectively.  
The 400 MHz 
1
H NMR spectrum (Figure 3.44) of compound 51 (Table 3.8) 
showed two sets of triplets and one doublet of aromatic proton signals at δ 7.43 (2H, t, 
J=7.4, H-4 and H-6), δ 7.51 (1H, t, J=7.5, H-5), and δ 7.80 (2H, d, J=3.3, H-3 and H-7) 
suggested the presence of mono substituted aromatic ring. In addition, it shows an 
extreme example of quadropole broadening, where the NH2 absorption extends from δ 
5.80-6.27 as a broad peak.  
The 
13
C NMR spectrum (Figure 3.45) was in agreement with the molecular 
formula deduced from the mass spectrum, accounting for all 7 carbons. In the 
13
C NMR 
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spectrum, there are only 5 carbon peaks. There were 2 overlapping carbons appeared at 
the same chemical shift which has equivalent environment in the aromatic ring. These 
signals appeared at δ 127.3 (C-3 and C-7) and at δ 128.6 (C-4 and C-6). The DEPT 
experiment revealed five methines and two quaternary carbon signals. Finally, from the 
analysis of DEPT, HMQC and COSY and spectral data compared with literature values, 
it is confirmed that compound 51 was benzamide. 
[104]
 
 
Table 3.8. 
1
H NMR (in CDCl3, 400MHz) and 
13
C NMR (in CDCl3, 100MHz) of 51 
Position δH, ppm (J in Hz) δC (ppm) 
1 - 169.5 
2 - 133.3 
3 7.80, d, J = 3.3 127.3 
4 7.43, t, J = 7.4 128.6 
5 7.51, t, J = 7.5 132.0 
6 7.43, t, J = 7.4 128.6 
7 7.80, d, J = 3.3 127.3 
NH2 5.80-6.27, br s - 
 
 
 
 119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.43: Mass Spectrum of Benzamide 51 
 
 
 
 
 
[M]
+
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Figure 3.44: 
1
H NMR Spectrum of Benzamide 51 
H-3, 
H-7 
H-5 
H-4, 
H-6 
Solvent, CDCl3 
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Figure 3.45: 
13
C NMR Spectrum of Benzamide 51 
C-1 
C-2 
C-5 
C-4, C-6 
C-3, C-7 
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3.2 Biological Activities of Cyptocarya nigra (Lauraceae) 
3.2.1    Antiplasmodial Activities Against Plasmodium falciparum Strains 
Malaria is caused by five species of parasites of the genus Plasmodium that 
affect humans (P.falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi). Malaria 
due to P. falciparum is the most deadly form. According to the latest data by WHO, the 
estimation incidence of malaria has remained unacceptably high. There were about 219 
million cases of malaria in 2010 and an estimated 660 000 deaths.
[105]
 A major factor in 
the continuing burden of malaria is the spread of parasites resistant to front-line anti-
malarials such as chloroquine and sulphadoxine/ pyrimethamine, and artemisinine.
[106]
 
Table 3.9. In vitro Antiplasmodial Activities of Alkaloids from Cryptocarya nigra 
Sample Antiplasmodial Activity (IC50) 
 g/mL M
Dichloromethane extract 2.82 - 
N-Methylisococlaurine 46 1.62 5.40 
Atherosperminine 11 1.80 5.80 
2-hydroxylatherosperminine 20 0.25 0.750 
Chloroquine - 0.090 ± 28.9 
Artemisinine - 0.002 ± 0.001 
 
The compounds isolated from the bark of Cryptocarya nigra were tested for 
antiplasmodial activity based on the promising screening results of dichloromethane 
(DCM) crude extract (IC50 = 2.82 μg/mL). The in vitro antiplasmodial activity of 
compounds isolated from Cryptocarya nigra against a chloroquine sensitive strain of P. 
falciparum (K1 strain) is summarized in Table 3.9. 2-Hydroxylatherosperminine 20 
displayed the strongest inhibition activity, with an IC50 value of 0.75 μM, followed by 
N-methylisococlaurine 46 and atherosperminine 11 with an IC50 value of 5.40 μM and 
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5.80 μM respectively. These alkaloids have not been reported to have their 
antiplasmodial activity. 
 
3.2.2    Antioxidant Activities 
Recent development in medicinal field reports a number of disease associated 
with free radicals. The risk of diseases due to oxidative stress is compounded by 
unhealthy lifestyle, exposure of chemicals, pollution, cigarette smoking, drugs, illness, 
and stress etc. Antioxidants are the substances which can scavenge free radicals and 
help to decrease the incidence of oxidative stress induced damage. 
[119]
  
In the present study, the antioxidant activity of isolated compounds of 
Cryptocarya nigra was determined using DPPH radical scavenging assay, reducing 
power assay, and metal chelating assay. DPPH assay has been widely used to determine 
the free radical scavenging activity of various plants. FRAP assay was frequently used 
to study the antioxidant activity of plants. It measures the ferric to ferrous ion reduction 
in the presence of antioxidant. The reducing power of a sample may serve as important 
pointer of its potential antioxidant capacity. It showed the reducing capacity of a 
compound and is able to act as a significant indicator for antioxidant activity. Metal 
chelating activity is significant as it reduces the concentration of the catalyzing 
transition metal in lipid peroxidation through the Fenton reaction.
 [120] 
N-Methylisococlaurine 46 showed the highest scavenging activity of DPPH free 
radicals with IC50 = 29.56 µg/ml and reducing power at 78.54% in comparison to 
atherosperminine 11. However atherosperminine 11 showed higher metal chelating 
activity than N-methylisococlaurine 46 at IC50 = 42.87ug/ml and IC50 50.08ug/ml 
respectively. The high DPPH and reducing power antioxidant activity of N-
methylisococlaurine 46 could be due to its hydroxyl group which donated the electron 
to form stable free radicals and possess the ability to chelate metal. Benzylisoquinoline 
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alkaloid of tetrandrine has been reported to have antioxidant activity 
[108]
. The 
antioxidant activity of phenanthrene atherosperminine 11 is still not known. However 
there has been reported that the phenanthrene have shown an effect on glutathione 
reductase that increases antioxidant activity in fish of olive flounder, Paralichthys 
olivaceus 
[109]
.  
 
Table 3.10. Antioxidant Activities of Alkaloids from Cryptocarya nigra 
 
Compound Name 
IC50 DPPH 
Activity 
(ug/ml) 
 
% FRAP 
IC50 Metal 
Chelating 
Activity (ug/ml) 
N-methylisococlaurine 46 29.56 78.54 50.08 
Atherosperminine         11 54.53 70.66 42.87 
Ascorbic acid (Standard) 13.69   
EDTA (Standard)  83.74  
 BHA (Standard)   19.60 
 
 
 In DPPH assay and FRAP assay, compound 11 and 46 showed moderate 
activity compared to standards reference used ascorbic acid and EDTA respectively, 
while in Metal Chelating Assay both compound shows weak activity compared to the 
standard reference, BHA. The results showed that the N-methylisococlaurine 46 and 
atherosperminine 11 exhibited both iron binding and antiplasmodial activity. These 
suggested that there are iron requirement in host-parasite interaction 
[110, 111]
 for oxygen 
transport, respiration and enzymes activities. Thus, metal chelating ability of 
compounds could be important criteria in antimalarial treatment. The mechanism of 
action of iron chelators are still not known and further investigation need to be carried 
out on N-methylisococlaurine 46 and atherosperminine 11 as antimalarial treatment 
through metal chelating mechanism. Since both compounds exhibited antiplasmodial 
effect, the antioxidant activities may be able to stimulate immune system 
[112, 113]
. This 
will provide a good potential for antimalarial therapy.  
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Further investigations have been made to test the isolated compounds for their 
antiplasmodial and antioxidant activity. Only N-methylisococlaurine 46 and 
atherosperminine 11 were tested for both activities. According to Reis, et.al, the 
combination of chloroquine and two antioxidant agents, at the first signs of cerebral 
malaria prevented both inflammatory and vascular changes in the tissues of the brain, as 
well as the development of persistent cognitive damage. The addition of antioxidants 
did not diminish the efficacy of chloroquine in eliminating Plasmodia from the blood. 
The authors suggested that these antioxidant drugs should be studied as additive therapy 
for antimalarial drugs in clinical trials in order to investigate their potential to reduce or 
prevent cognitive damage after cerebral malaria 
[114]
. Additionally, recent studies by 
Percario, et al. (2012), suggested in their studies on ‘Oxidative Stress in Malaria’ that 
the use of antioxidant supplements of synthetic or natural origin may constitute a far 
more effective adjuvant antimalarial strategy that causes less damage to the host 
[115]
. 
 
  
 
 
 
 
CHAPTER 4 
 
 
CONCLUSION
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CHAPTER 4 
CONCLUSION 
 
Cryptocarya nigra of Lauraceae family has not been studied for their alkaloidal 
content. The chemical study on the dried barks and leaves of Cryptocarya nigra 
afforded eight known compounds namely (+)-N-methylisococlaurine 46, 
atherosperminine 11, 2-hydroxyatherosperminine 20, noratherosperminine 47, 
isocorydine 48, norisocorydine 49, argentinine 50 and benzamide 51. The leaves of 
Cryptocarya nigra underwent the acid-base extraction, while the bark part was extracted 
without using acid-base. Both extracts were subjected to chromatographic analysis. The 
compounds obtained from both methods of study are listed in Table 4.1. 
 
Table 4.1: Compounds Isolated from Cryptocarya nigra 
Without acid base extraction 
method (Dried Bark) 
Acid – base extraction 
method (Dried Leaves) 
N-Methylisococlaurine 46 Isocorydine 48 
Atherosperminine 11 Norisocorydine 49 
2-hydroxyathersperminine 20 Argentinine 50 
Noratherosperminine 47 Benzamide 51 
 
All the structures of the alkaloids were established by spectroscopic analysis, 
particularly NMR experiments. 
 
The Cryptocarya genus is rich in various types of alkaloids. For example, pavine 
alkaloids was found in Cryptocarya chinensis 
[21]
, phenanthrene alkaloids occured in 
Cryptocarya crassinerva 
[22]
 and benzylisoquinoline alkaloids in Cryptocarya rugulosa 
[96]
. Based from this studies, it can be concluded that the major type of alkaloids 
occurred in Cryptocarya nigra and are benzylisoquinolines, with (+)-N-
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methylisococlaurine 46 as the major compound. On top of that, there is another type of 
alkaloid, namely aporphine or phenanthrene types of alkaloids were found in the 
Cryptocarya nigra. These types of alkaloids have never been isolated from this plant.  
 
At present, there is no report on the antiplasmodial and antioxidant properties of 
Cryptocarya nigra. Out of 8 compounds isolated from this study, three are  alkaloids,  
(+)-N-methylisococlaurine 46,  atherosperminine 11 and 2-hydroxyatherosperminine 20 
which mildly inhibited in vitro growth of a chloroquine sensitive strain of Plasmodium 
falciparum (K1 strain), with the highest inhibition shown by compound 20. In addition, 
both compounds 46 and 11 exhibited mild antioxidant activity. Therefore it can be 
summarized that the compounds tested showed some activity on antiplasmodial and 
antioxidant thus could be natural lead compounds for development of potential drugs for 
antimalaria since antioxidants are said to be an additive therapy for antimalarial, 
however further mechanistic studies must be performed first. The antiplasmodial and 
antioxidant data suggested that the barks extract of Cryptocarya nigra is a potential 
source of new antiplasmodial natural lead compounds having antioxidant potential. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER 5 
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CHAPTER 5 
EXPERIMENTAL 
5.1 General Experimental Procedures 
5.1.1 Solvents 
The solvents used in this work were dichloromethane, methanol and hexane. All 
solvents are from AR grade except those that are used for folk extractions (distilled). 
Other chemicals were hydrochloric acid, ammonia solution and sodium sulphate 
anhydrous. 
5.1.2 Instrumentation  
The ultraviolet spectra were obtained in methanol (MeOH) on Shimazu UV-250. 
Meanwhile, the infrared spectra were obtained with methanol as solvent on a Perkin 
Elmer 16000 spectrometer. Mass spectra were obtained using Agilent Technologies 
6530 accurate-mass e-TOF LC/MS, with a ZORBAX Eclipse XDB-CI8 rapid resolution 
HT 4.6 mm x 50 mm x 1.8 mm column. 
The 
1
H, 
13
C and 2D NMR spectra was recorded in deuterated chloroform using 
JEOL LA 400 FT NMR and JOEL ECA 400 FT NMR spectrometer system; chemical 
shift are reported in part per million (ppm) scales and the coupling constant are given in 
hertz (Hz). 
5.1.3 Chromatography 
Alumina supported silica gel 60 F254 plates were used for visualized isolated 
compounds based on the spot of TLC (thin layer chromatography). The plates were 
activated at 100˚C for one hour and stored in a desiccator until needed. TLC spots were 
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visualized under ultra-violet light (254 and 365nm) using the model UVGL-58 followed 
by spraying with the Dragendorff’s reagent. 
Silica gel 604 F254 was used for preparative TLC. Mayer’s reagent and 
Dragendorff’s reagent were used for alkaloid screening and alkaloids spotting. 
5.1.4. Reagents 
5.1.4.1. Mayer’s Reagent (potassium mercuric iodide) 
Mercuric iodide (1.4 g) in distilled water (60 ml) mixed with potassium iodide 
(5.0 g) in water (10 ml). The mixture was then made up to 100 ml solution. A positive 
test result was indicated by the formation of white precipitation when the aqueous layer 
(acidified) is treated with 2-3 drops of Mayer’s reagent. 
5.1.4.2. Dragendorff’s reagent (potassium bismuth iodide) 
Solution A: Bismuth (III) nitrate (0.85 g) in a mixture of glacial acetic acid (10 ml) and 
distilled water (40 ml) 
Solution B: potassium iodide (8.0 g) in distilled water (200 ml) 
Stock solution: a mixture of equal volumes of both solution A and B 
Spray reagent: the stock solution (20 ml) was diluted in a mixture of acetic acid (20 ml) 
and distilled water (60 ml) 
A positive Dragendorff’s test was indicated by the formation of orange spots. 
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5.2. Plant Material 
The leaves of Cryptocarya nigra were collected at Hutan Simpan Ulu Sat, 
Machang, Kelantan by the phytochemical group of the Chemistry Department, Faculty 
of Science, University of Malaya. Identification was made by Mr Teo Leong Eng 
(University Malaya). Voucher specimen (KL 5272) was deposited at the herbarium of 
Department of Chemistry, University of Malaya, Kuala Lumpur, Malaysia. 
 
5.3. Extraction of Cryptocarya nigra 
Plant extractions were carried out by cold extraction or exhaustive extraction 
using the soxhlet extractor, following the general procedure describe below. 
In order to aggregate the nitrogen-containing compound in the plants, dried 
leaves of Cryptocarya nigra (1.9 kg) were soaked with hexane for 3 days. After that, the 
hexane were extracted and filtered and dried the sample under room temperature. The 
dried sample were then basified and moistened with 10% ammonia solution and left 
overnight. The materials were then extracted with dichloromethane (CH2Cl2) in a big 
flask for 3 days. To get more benefit, the materials were extracted by using soxhlet 
extractor successively checking for a Mayer’s negative test after each extraction. 
The dichloromethane extract of the leaves will be concentrated by using 
rotavapor to a volume of about 500 ml and were examine for alkaloid contents using 
thin layer chromatography and spotting with Dragendroff’s reagent. The 
dicholoromethane extracts were then repeatedly extracted with a solution of 5% 
hydrochloric acid until Mayer’s test is negative. The acidic aqueous were then basified 
with 10% ammonia solution until pH 11 and then re-extracted with dicholoromethane. 
The crude alkaloid fraction was obtained as a dark gummy residue after washing the 
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combined dichloromethane extracts with distilled water, drying over anhydrous sodium 
sulphate and evaporation under pressure. 
While the other part of Cryptocarya nigra was not subjected to the normal acid-
base extraction. In order to aggregate the alkaloids in the plants, 2.0 kg of dried bark of 
Cryptocarya nigra were soaked with hexane for 3 days to remove wax, chlorophyll, 
terpenoids and flavonoids. Sample was filtered and dried in room temperature. After the 
dried sample was basified with concentrated ammonia solution (25%) for two hours, the 
material was then extracted with dichloromethane in the big flask (cold extraction) for 
three days. The dichloromethane extract was dried under reduce pressure to get crude 
alkaloids in dark solid form. 
 
5.4. Isolation and purification 
 
 
The crude alkaloid was subjected to column chromatography over silica gel 60 
as stationary phase. The solvent system used for chromatography was dichloromethane 
with increasing portion of methanol (gradient elution system). The ratio of the solvent 
between CH2Cl2 and CH3OH were (100:0; 99:1; 98:2 96:4; 93:7; 90:10; 85:15; 80:10 
and 50:50) and finally 100% MeOH. Fractions were collected every 100 ml and each 
fraction was tested with aluminium TLC plate for their alkaloids. The alkaloid spots 
were first detected by UV light (254 and 366 nm) and confirmed by spraying with 
Dragendroff’s reagent. Fraction having spots with the same Rf values and stains were 
combined and treated as a group. The combined groups were then treated separately to 
isolate and purify its alkaloid content either by extensive column chromatography or 
preparative TLC. The isolation and purification procedures were summarized in the 
Scheme 5.1 and 5.2 
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Table 5.1: Chromatography Results of the Chemical Constituents of Cryptocarya nigra  
(bark) 
Compounds Solvent system 
(CH2Cl2: MeOH) 
Weight/mg  % Yield 
Noratherosperminine 47 98:2 1.5 mg 1.8 % 
Atherosperminine 11 96:4 15.0 mg 18.8 % 
2-hydroxyathersperminine 20 96:4 5.0 mg 6.3 % 
N-Methylisococlaurine 46 95:5 25.0 mg 31.3 % 
 
 
Table 5.2: Chromatography Results of the Chemical Constituents of Cryptocarya nigra 
(leave) 
Compounds Solvent system 
(CH2Cl2: MeOH) 
Weight/mg  % Yield 
Benzamide 51 99:1 13.7 mg 21.1 % 
Argentinine 50 97:3 1.3 mg 2.0 % 
Isocorydine 48 94:6 5.3 mg 8.2 % 
Norisocorydine 49 94:6 8.8 mg 13.5 % 
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CC: column chromatography 
 
PTLC: preparative thin layer chromatography 
 
 
 
Scheme 5.1: Isolation and Purification of Alkaloids from the Bark of Cryptocarya 
nigra. 
 
 
 
Cryptocarya nigra 
(Bark 2.0 kg) 
3.8 kg 
Dichloromethane extract 
(8 g) 
Fraction 
90-120 
Fraction 
183-200 
Fraction 
201-210 
CC CH2Cl2:MeOH 
Noratherosperminine 
47 
N-Methylisococlaurine 
46 Atherosperminine 
11 
2-
hydroxyatherosperminine 
20 
PTLC 
98:2 
PTLC 
96:4 
PTLC 
95:5 PTLC 
96:4 
 134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CC: column chromatography 
 
PTLC: preparative thin layer chromatography 
 
 
 
 
Scheme 5.2: Isolation and Purification of Alkaloids from the Leave of Cryptocarya 
nigra 
 
 
Cryptocarya nigra 
(Leaves 2.0 kg) 
Crude alkaloids mixture 
(6.5 g) 
 
CC CH2Cl2: MeOH 
 
Fraction 1-20 Fraction 90-
112 
Fraction 125-
172 
 
Benzamide 
51 
Argentinine 
50 
Norisocorydine 
49 
PTLC 
99:1 
PTLC 
98:2 
PTLC 
97:3 
Isocorydine 
48 
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5.5. Physical and Spectral Data of Isolated Compounds 
 
 
5.5.1 Cryptocaya nigra 
 
 
N-Methylisococlaurine 46                         :               brownish amorphous solid 
                                                                     : C18H21NO3 
UVmx (MeOH), nm                                      : 301  nm 
IRVmax cm
-1                                                                          
: 3266 and 2921 cm
-1
 
Mass spectrum m/z                                     : 300.16 
[α]  : +29.4° 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.1 
13
C NMR (CDCl3) δ ppm                            : See Table 3.1 
 
 
 
Atherosperminine 11                                :               brownish amorphous solid 
                                                                     : C20H23NO2 
UVmx (MeOH), nm                                      : 217, 227, 256, 306 and 345 nm 
IRVmax cm
-1                                                                          
: 1600 cm
-1
 
Mass spectrum m/z                                     : 310.18 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.2 
13
C NMR (CDCl3) δ ppm                            : See Table 3.2 
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2-hydroxyatherosperminine 20                :               brownish amorphous solid 
                                                                     : C20H23NO3 
UVmx (MeOH), nm                                      : 286 and 296 nm 
IRVmax cm
-1                                                                          
: 3412 cm
-1
 
Mass spectrum m/z                                     : 326.18 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.3 
13
C NMR (CDCl3) δ ppm                            : See Table 3.3 
 
 
 
Noratherosperminine 47                           :               brownish amorphous solid 
                                                                     : C19H21NO2 
UVmx (MeOH), nm                                      : 258, 308 and 347 nm 
IRVmax cm
-1                                                                          
: 2917, 2849 and 3363 cm
-1
 
Mass spectrum m/z                                     : 296.16 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.4 
13
C NMR (CDCl3) δ ppm                            : See Table 3.4 
 
 
Isocorydine 48                                            :               brownish amorphous powder 
                                                                     : C20H24NO4 
UVmx (MeOH), nm                                      : 270 and 310 nm 
IRVmax cm
-1                                                                          
: 3202 cm
-1
 
Mass spectrum m/z                                     : 342.2 
 : +196° 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.5 
13
C NMR (CDCl3) δ ppm                            : See Table 3.5 
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Norisocorydine 49                                     :                     brownish amorphous powder 
                                                                     : C19H22NO4 
UVmx (MeOH), nm                                      : 270 and 310 nm 
IRVmax cm
-1                                                                          
: 2936 and 3500 cm
-1
 
Mass spectrum m/z                                     : 328.2 
 : +158.5° 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.6 
13
C NMR (CDCl3) δ ppm                            : See Table 3.6 
 
 
 
 
Argentinine 50                                           :               brownish amorphous solid 
                                                                     : C19H21NO2 
UVmx (MeOH), nm                                      : 245, 256, 291 and 345 nm 
IRVmax cm
-1                                                                          
: 2922 and 3367 cm
-1
 
Mass spectrum m/z                                     : 296 
1
H NMR (CDCl3) δ, ppm                            : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
See Table 3.7 
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Benzamide 51                                             :               Crystalline needle 
                                                                     : C7H7NO 
Melting point                                               : 125-127 ºC 
UVmx (MeOH), nm                                      : 294 and 280 nm 
IRVmax cm
-1                                                                          
: 1646 and 3368 cm
-1
 
Mass spectrum m/z                                     : 121 
1
H NMR (CDCl3) δ, ppm                            : See Table 3.8 
13
C NMR (CDCl3) δ ppm                            : See Table 3.8 
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5.6. Experimental for Antioxidant Activities 
5.6.1    DPPH Assay 
The DPPH antioxidant assay was determined as described by Shimada et al. 
[116]
. 
Briefly, 0.1 mM DPPH (1 mL) dissolved in ethanol was added to an ethanol solution (3 
mL) of the tested compound at different concentrations (0, 50, 100, 150, 200 mg/mL). 
An equal volume of ethanol was added in the control test. The mixture was shaken 
vigorously and allowed to stand at room temperature for 30 min. Then the absorbance at 
517 nm was measured with a UV–VIS spectrophotometer.  The percentage of 
scavenging of DPPH was calculated using the following equation: 
 
DPPH scavenging effect (%) = ((Aº - A1) / Aº) x 100 
 
Where Ao is the absorbance of the control reaction and A1 is the absorbance in 
the presence of the sample. Ascorbic acid (purity 99.0%) was purchased from Sigma 
used as the standard references. 
 
5.6.2    Reducing Power Assay 
The reducing power was determined using the method of Oyaizu, 1986 
[117]
. The 
tested compounds (0.5 mL) at different doses (0, 50, 100, 150, 200 mg/mL) were mixed 
with phosphate buffer (0.5 mL, 0.2 M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6] 
(0.5 mL, 1%). The mixture was then incubated at 50°C for 20 min. A portion of 
trichloroacetic acid (0.5 mL, 10%) was added to the mixture, which was then 
centrifuged for 10 min at 3000 rpm (1000 g). The upper layer of solution (0.5 mL) was 
mixed with distilled water (0.5 mL) and FeCl3 (0.1 mL, 0.1%) for 10 min, and then the 
absorbance was measured at 700 nm in a spectrophotometer. The EDTA (purity 99.0%) 
was purchased from Sigma and was used as the standard reference. 
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5.6.3    Metal Chelating Activity Assay 
The chelation of ferrous ions was estimated according to the method of Dinis, et 
al. 1994 
[118]
. Briefly, 0.95 mL of tested compounds at different doses (0, 50, 100, 150, 
200 mg/mL) were added to a solution of 50 µL FeCl2 (2 mM). The reaction was 
initiated by the addition of 200 µL ferrozine (5 mM), and then the mixture was shaken 
vigorously and left standing at room temperature for 10 min. After equilibrium had been 
reached, absorbance of the solution was measured spectrophotometrically at 562 nm. 
Distilled water (200mL) instead of fferozine solution was used as a blank, which was 
used for error correction because of unequal colour of the sample solution. The 
percentage of inhibition of ferrozine-Fe
2+
 complex (ferrous ion – chelating ability) of 
each sample was calculated according to the following formula: 
 
% inhibition = [(Abscontrol – Abssample)/Absstandard] x 100 
 
where, Abscontrol = absorbance reading of control 
Abssample = absorbance reading of sample 
Absstandard = absorbance reading of standard reference 
 
 The IC50 value was determined from the graph of inhibition againts concerntration. 
BHA (purity 96.0%) was purchased from Acros organic and was used as the standard 
reference. 
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5.7. Experimental for Antiplasmodial Activities 
 
The dichloromethane extract and the isolated compounds were assayed for in 
vitro antiplasmodial activity against the Plasmodium falciparum, K1 isolate (resistance 
strain). Briefly the methodology involves Malaria culture as discussed by Trager and 
Jensen, (1976) with some modification. The synchronization of the malaria culture to 
one stage is according to Lambros C and Vanderberg P., 1979. Chloroquine and 
artermisine were used as positive control. The antiplasmodial activity of each compound 
was expressed as an IC50 value, defined as the concentration of the compound causing 
50% inhibition of parasite growth relative to an untreated control.
[107]
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Abstract: A dichloromethane extract of the stem bark of Cryptocarya nigra showed 
strong  
in vitro inhibition of Plasmodium falciparum growth, with an IC50 value of 2.82 
μg/mL. The phytochemical study of this extract has led to the isolation and 
characterization of four known alkaloids: (+)-N-methylisococlaurine (1), 
atherosperminine (2), 2-hydroxyathersperminine (3), and noratherosperminine (4). 
Structural elucidation of all alkaloids was accomplished  
by means of high field 1D- and 2D-NMR, IR, UV and LCMS spectral data. The  
isolated extract constituents (+)-N-methylisococlaurine (1), atherosperminine (2) 
and  
2-hydroxy-atherosperminine (3) showed strong antiplasmodial activity, with IC50 
values of 5.40, 5.80 and 0.75 μM, respectively. In addition, (+)-N-
methylisocolaurine (1) and atherosperminine (2) showed high antioxidant activity 
in a DPPH assay with IC50 values of 29.56 ug/mL and 54.53 ug/mL respectively. 
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Compounds 1 and 2 also both showed high antioxidant activity in the FRAP assay, 
with percentages of 78.54 and 70.66 respectively and in the metal chelating assay, 
with IC50 values of 50.08 ug/mL and 42.87 ug/mL, respectively. 
Keywords: Plasmodium falciparum; Cryptocarya nigra; Lauraceae; antioxidant; 
antiplasmodial; activity 
 
 
1. Introduction 
Malaria is caused by five species of parasites from the genus Plasmodium: P. falciparum, 
P. vivax, P. ovale, P. malariae, P. knowlesi and P. falciparum is the most deadly form that 
affects humans [1]. According to the latest data from the WHO, the estimated incidence of 
malaria has remained unacceptably high. There were about 219 million cases of malaria in 
2010 and an estimated 660,000 deaths [2]. A major factor in the continuing burden of malaria 
is the spread of parasites resistant to front-line anti-malarials such as chloroquine and 
sulphadoxine/ pyrimethamine, and artemisinin [3]. 
Malaysia, being host of one of the oldest and richest forest ecosystems in the World with a 
reported more than 15,000 plant species is an excellent source of natural bioactive 
compounds [4]. In our continuing efforts to search for new antiplasmodial agents [5–10], we 
report herein our phytochemical studies on Cryptocarya nigra (Lauraceae), whose 
dichloromethane extract showed potent antiplasmodial activity with an IC50 value 2.82 μg/mL. 
This plant is widely distributed in Peninsular Malaysia, Sumatra and Borneo, and it is 
locally known as ‘Medang’ [11]. The genus Cryptocarya belonged to the family Lauraceae 
which comprises of more than 350 species of which 19 species are found in Malaysia [12,13]. 
This species is a medium sized tree that grows up to 10 m tall. Based on previously reported 
phytochemical and pharmacological studies, the genus Cryptocarya are known to be prolific 
producers of flavonoids, chalcones, lactones, α-pyrones and mainly alkaloids [14–24] with 
varied biological activities. A preliminary study on the leaves of the Cryptocarya nigra 
reported the presence of coumarins and flavonoids and their cytotoxic activity against murine 
leukemia P-388 cells [25]. However, no study has been reported on the alkaloidal content, 
antiplasmodial and antioxidant activities of Cryptocarya nigra extracts 
The phytochemical study on the stem bark of Cryptocarya nigra has now led to the isolation 
of four known alkaloids; (+)-N-methylisococlaurine (1) [26], atherosperminine (2) [27], 2-
hydroxyathersperminine  
(3) [24], and noratherosperminine (4) [28] (Figure 1). Alkaloids 1–3 were evaluated for their 
antiplasmodial activity and alkaloids 1 and 2 were also subjected to antioxidant assays. 
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Figure 1. Structures of compounds 1–4. 
 
2. Results and Discussion 
Extensive chromatographic analysis of the dicholoromethane extract (DCE) of the bark of 
Cryptocarya nigra afforded one benzylisoquinoline alkaloid, (+)-N-methylisococlaurine (1), and 
three phenanthrene alkaloids: atherosperminine (2), 2-hydroxyathersperminine (3), and 
noratherosperminine (4). The structure of each compound was characterized by analysis of its 
spectroscopic data and by comparison of its NMR, IR, UV and MS data with literature values 
[24,26–28]. 
Phenanthrene alkaloids are derivatives of phenanthrene with a 1-(2-aminoethyl) side 
chain. They are a very rare type also known as “seco-aporphine” alkaloids, probably formed 
biogenetically from an aporphine precursor through opening of ring B [29]. Phenanthrene 
alkaloids have been reported to exhibit antimicrobial activity, cytotoxicity, and dopamine 
receptor stimulation effects [27,30,31]. 
2.1. Antiplasmodial Activity  
The compounds isolated from the bark of Cryptocarya nigra were tested for 
antiplasmodial activity based on the promising screening results of the DCE (IC50 = 2.82 
μg/mL). The in vitro antiplasmodial activity of compounds isolated from Cryptocarya nigra 
against a chloroquine resistant strain of  
P. falciparum (K1 strain) is summarized in Table 1. Compound 3 displayed the strongest 
inhibition activity, with an IC50 value of 0.75 μM, followed by compound 1 and compound 2 
with IC50 values  
of 5.40 μM and 5.80 μM, respectively. These alkaloids have no previous record of any  
antiplasmodial activity.  
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Table 1. In vitro Antiplasmodial Activities of Alkaloids from Cryptocarya nigra. 
 
Sample 
Antiplasmodial Activity 
* The % of growth inhibition or IC50 
 g/mL M
1 1.62 5.40 
2 1.80 5.80 
3 0.25 0.75 
4 nt 
†
 nt 
†
 
Chloroquine 90.39 ± 28.85 **  
Artemisinin 2.42 ± 1.06 **  
* Results are recorded as the % of growth inhibition or IC50. Notes: nt 
†—not tested; ** unit in 
nM. 
2.2. Antioxidant Activity  
Compound 1, a benzylisoquinoline, showed high scavenging activity towards the free 
radical DPPH at IC50 = 29.56 µg/mL and high reducing power at 78.54% as compared to 
compound 2 (Table 2). However compound 2 showed higher metal chelating activity than 
compound 1 at IC50 = 42.87 ug/mL and IC50 50.08 ug/mL, respectively. The high DPPH and 
FRAP antioxidant activity of compound 1 may be due to its hydroxyl group that could donate 
an electron to free radicals and possesses the ability to chelate metals. In addition, Jee 
reported that the phenanthrenes have shown an effect on glutathione reductase that increases 
antioxidant activity in the fish Paralichthys olivaceus (olive flounder) [32]. Thus, compound 
1 and compound 2 are good reductants with the ability to chelate metals and presented pro-
oxidant activity. 
Table 2. Antioxidant Activities of Alkaloids from Cryptocarya nigra. 
Compound Name 
IC50 DPPH 
Activity (ug/mL) 
% FRAP 
IC50 Metal Chelating 
Activity (ug/mL) 
N-Methylisococlaurine (1) 29.56 78.54 50.08 
Atherosperminine (2) 54.53 70.66 42.87 
Ascorbic acid (Standard) 13.69   
EDTA (Standard)  83.74  
BHA (Standard)   19.60 
The results showed that compounds 1 and 2 exhibited both iron binding and 
antiplasmodial activity. This suggests that there is iron requirement in host-parasite 
interactions [33,34] for oxygen transport, respiration and enzymes activities. These results 
indicate that there may be a correlation between antiplamodial activities and iron chelating in 
metal chelating [35]. Thus, metal chelating ability has potential in antimalarial treatment. The 
mechanism(s) of action of iron chelators are still not known and further investigation must be 
carried out on compounds 1 and 2 in order to elucidate their metal chelating mechanism and 
their potential as antimalarial agents. The antioxidant effect might play a major role in 
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inhibiting the actions of the parasites, but it may also stimulate the immune system of 
malarial victims [36], therefore being a good candidate for antimalarial therapy. 
According to Reis et al., the combination of chloroquine and two antioxidant agents, 
prevented both inflammatory and vascular changes in the tissues of the brain at the first signs 
of cerebral malaria, as well as the development of persistent cognitive damage. The addition 
of antioxidants did not diminish the efficacy of chloroquine in eliminating Plasmodia from 
the blood. The authors suggested that these antioxidant drugs should be studied as an additive 
therapy for antimalarial drugs in clinical trials in order to investigate their potential to reduce 
or prevent cognitive damage after cerebral malaria [37]. Additionally, recent studies by 
Percario et al. on oxidative stress in malaria [38] have suggested that the use of antioxidant 
supplements of synthetic or natural origin may constitute a far more effective adjuvant 
antimalarial strategy that causes less damage to the host. 
3. Experimental 
3.1. General 
Spectra were recorded on the following instruments: UV: Shimadzu UV-250 UV-Visible 
spectrophotometer; IR: Perkin Elmer 1600; NMR: JEOL ECA 400 MHz; LCMS-IT-TOF: 
Shimadzu. All solvents, except those used for bulk extraction were AR grade. Silica gel 60 
F254 was used for column chromatography. Glass and aluminum-supported silica gel 60 
F254 plates were used for preparative TLC. TLC spots were visualized under UV light (254 
and 365 nm) followed by spraying with Dragendorff’s reagent for alkaloid detection. 
 
3.2. Plant Material 
The bark of Cryptocarya nigra was collected at Hutan Simpan Ulu Sat, Machang, 
Kelantan (Malaysia) by the phytochemical group of the Department of Chemistry, Faculty of 
Science, University of Malaya. A voucher specimen (KL5272) has been deposited at the 
Herbarium of the Department of Chemistry, University Malaya, Kuala Lumpur, Malaysia.  
3.3. Extraction and Isolation 
The air-dried ground bark of the plant (2.0 kg) was first exhaustively extracted twice with 
hexane (14 L) for a 3-day period. The hexane extracts were combined and the solvent 
evaporated. The dried plant material were then made alkaline and moistened with 25% 
NH4OH (1 L) for 2 h. It was then macerated with CH2Cl2 (14 L) twice for a 3-day period. 
After filtration, the supernatant obtained was concentrated under reduced pressure using a 
rotary evaporator to a volume of 500 mL and tested for alkaloid content (using TLC and 
confirmed by spraying with Dragendorff’s reagent). The extract was finally concentrated and 
dried to give 15.0 g of extract designated as the DCE. The crude alkaloid extract (8.0 g) was 
subjected to column chromatography over silica gel using CH2Cl2 and methanol mixtures 
(100:0, 99:1, 98:2, 97:3, 96:4, 95:5, 90:10, 80:20, and 70:30) and finally 100% methanol as 
 162 
 
eluent to obtain twenty fractions. Further purification of fraction 16 by Preparative Thin 
Layer Chromatography (PTLC) yielded major alkaloid 1 (25.0 mg, MeOH-CH2Cl2; 95:5: 
saturated with NH4OH). In addition, known compounds 2 (15.0 mg, MeOH-CH2Cl2; 96:4: 
saturated with NH4OH), 3 (5.0 mg, MeOH-CH2Cl2; 96:4: saturated with NH4OH), and 4 (1.5 
mg, MeOH-CH2Cl2; 98:2: saturated with NH4OH) were obtained after purification of fraction 
17. 
3.4. Determination of Antiplasmodial Activity 
The samples were sent to the Institute for Medical Research, Kuala Lumpur (IMR) for 
antiplasmodial screening. DCE and the isolated compounds were assayed for in vitro 
antiplasmodial activity against the Plasmodium falciparum, K1 isolate (resistant strain). 
Briefly the methodology involves malaria culture as discussed by Trager and Jensen [39] 
with some modifications. The synchronization of the malaria culture to one stage is according 
to Lambros and Vandernerg [40]. Chloroquine and artemisinin were used as positive controls. 
The antiplasmodial activity of each compound was expressed as an IC50 value, defined as the 
concentration of the compound causing 50% inhibition of parasite growth relative to an 
untreated control. 
3.5. Determination of Antioxidant Assay 
3.5.1. DPPH Assay 
The DPPH antioxidant assay was determined as described by Shimada et al. [41]. Briefly, 
0.1 mM DPPH (1 mL) dissolved in ethanol was added to an ethanol solution (3 mL) of the 
tested compound at different concentrations (0, 50, 100, 150, 200 µg/mL). An equal volume 
of ethanol was added in the control test. The mixture was shaken vigorously and allowed to 
stand at room temperature for 30 min. Then the absorbance at 517 nm was measured with a 
UV–VIS spectrophotometer. The percentage of scavenging of DPPH was calculated using the 
following equation: 
DPPH scavenging effect (%) =  (1) 
where A
o
 is the absorbance of the control reaction and A1 is the absorbance in the presence 
of  
the sample. 
3.5.2. Ferric Reducing Power Assay (FRAP) 
The reducing power was determined using the method of Oyaizu [42]. The tested 
compounds  
(0.5 mL) dissolved in ethanol at different doses (0, 50, 100, 150, 200 µg/mL) were mixed 
with phosphate buffer (0.5 mL, 0.2 M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6] (0.5 
mL, 1%). The mixture was then incubated at 50 °C for 20 min. A portion of trichloroacetic 
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acid (0.5 mL, 10%) was added to the mixture, which was then centrifuged for 10 min at 3000 
rpm (1000 g). The upper layer of solution (0.5 mL) was mixed with distilled water (0.5 mL) 
and FeCl3 (0.1 mL, 0.1%) for 10 min, and then the absorbance was measured at 700 nm in a 
spectrophotometer. EDTA at different concentrations (2.5 µg/mL to 40 μg/mL) was used as 
standard reference. The reducing power activity was expressed as percentage of absorbance 
compared with EDTA. 
3.5.3. Metal Chelating Activity Assay 
The chelation of ferrous ions was estimated according to the method of Dinis et al. [43]. 
Briefly, tested compounds dissolved in ethanol (0.95 mL, at different doses of 0, 50, 100, 
150, 200 µg/mL) were added to a solution of FeCl2 (2 mM, 50 µL). The reaction was initiated 
by the addition of ferrozine (5 mM, 200 µL), and then the mixture was shaken vigorously and 
left standing at room temperature for 10 min. After equilibrium had been reached, absorbance 
of the solution was measured spectrophotometrically at 562 nm. The percentage of inhibition 
of ferrozine-Fe
2+
 complex of each sample was calculated according to the following formula: 
% inhibition = [(Abscontrol – Abssample)/Abscontrol] × 100 (2) 
where, Abscontrol = absorbance reading of control and Abssample = absorbance reading of 
sample. The IC50 value was determined from the graph of percentage inhibition against 
concentration. 
4. Conclusion 
A phytochemical study on dried bark of Cryptocarya nigra afforded four known alkaloids 
1–4.  
The alkaloids (+)-N-methylisococlaurine (1), atherosperminine (2) and 2-
hydroxyatherosperminine (3) strongly inhibited in vitro growth of a chloroquine resistant 
strain of Plasmodium falciparum (K1 strain), with the strongest inhibition shown by 
compound 3. In addition, both compounds 1 and 2 exhibited good antioxidant activity, 
therefore these compounds could be potential candidates as antimalarial agents since 
antioxidants are said to be an additive therapy for malaria. The antiplasmodial and 
antioxidant data suggested that the bark extract of Cryptocarya nigra is a potential source of 
new antiplasmodial agents having antioxidant potential. 
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